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ABSTRACT 
Clinical practice guidelines (CPGs) are viewed by many people with interests in health 
care as valuable tools for reducing practice variations that undermine patient outcomes and 
increase medical costs. However, guidelines themselves vary in quality. Assessment tools 
generally base quality measures on strength of guidelines’ evidence base, but particularly for 
newly emerging applications of ultrasound, standards for measuring guideline quality are 
controversial. The validity of a guideline is considered likely when strong research-based 
evidence supports its recommendations, but for newer medical procedures such as emerging 
ultrasound applications, available evidence is sparse.  Existing assessment tools must be 
modified if they are effectively to measure the validity of these guidelines built on immature 
evidence.  
Focusing on ways document drafting affects CPG validity, this study rated six guidelines 
using the Appraisal of Guidelines Research and Evaluation (AGREE) tool which was customized 
according to categories of guideline purposes and their differing features of validity. Fine-tuning 
AGREE in this way may create a more consistent, informative method of evaluating guidelines 
for emerging applications, and standards established in such an instrument may be useful as a 
template during the guideline development process.  
Results from my analyses illuminate several common omissions that weakened 
documents. Most guidelines did not describe an updating procedure or identify areas for future 
research, but results also highlighted some highly effective techniques for building validity. 
Notable examples include providing full credentials for expert drafters, and embedding statement 
references directly in the text. From the results of the analysis, I conclude that, although the 
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adapted assessment tool I used needs additional adjustment, it may refine analysis of guidelines 
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CHAPTER ONE: INTRODUCTION 
During the last several years the practice of medicine has come under intense scrutiny, 
both from external entities and from within the medical community itself.  While the rapidly 
advancing science of medicine has produced tremendous diagnostic and therapeutic tools, the 
cost of medical care has spiraled out of control, with no end in sight. Moreover, patient safety at 
the hands of medical caregivers has been called into question. Concerns about these two issues – 
patient safety and medical costs – have precipitated a major reappraisal of the medical system 
and delivery of health care in the United States.   
How can we provide care that is better and more cost-effective?  Fundamental to this 
question is the problem of unwarranted practice variation leading to inconsistent care and a 
spectrum of practices for any given application ranging from best, most effective to ineffective 
and even dangerous.  Basing care decisions on “best practices” as defined in clinical practice 
guidelines (CPGs) is viewed by many as a solution, but for some applications there are multiple 
and differing guidelines, and for some emerging applications there are as yet no guidelines at all 
(Carter 1649). 
My thesis examines clinical practice guidelines, with particular focus on how 
construction of guideline documents affects overall guideline quality. To establish context for 
discussing written communication issues, I explore the role of CPGs in promoting best clinical 
practices, how the quality of existing guidelines can be assessed, and how future guidelines 
might be developed and constructed to reduce unwarranted practice variation and exert 
maximum positive impact on patient outcomes and cost of care. My thesis examines the role of 
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guidelines in promoting best clinical practices, how the quality of existing guidelines can be 
assessed, and how future guidelines might be developed and constructed to reduce unwarranted 
practice variation and exert maximum positive impact on patient outcomes and cost of care. In 
the sections that follow I describe the patient safety and cost issues associated with practice 
variation, and I discuss how those problems precipitated a proliferation of CPGs. I define the 
distinguishing characteristics of these documents and examine methods of assessing CPG quality. 
Finally, I explore special demands associated with developing guidelines for emerging 
applications. This background information will lay a foundation for construction of a guideline 
development template the American Institute of Ultrasound in Medicine, along with its 
collaborative partners, can use to produce useful, high quality guidelines for emerging 
applications.  
I propose that three major challenges are likely to present themselves for developers of 
emerging applications guidelines.  First, there is the question of whether, as opponents will 
charge, it is even appropriate to devise guidelines for narrow exams to be performed by 
clinicians who are not ultrasound specialists. And indeed the question of appropriateness should 
be addressed in such a guideline. The second challenge will be overcoming potential 
philosophical discord among a diverse group of practitioners practicing in a variety of settings 
with a variety of skill sets. Third, for novel applications, there will be very little evidence on 
which to base guideline recommendations.  Each of these theoretical issues presents challenges 
for content experts and for technical communicators drafting the documents.    
In my thesis I propose to discuss these guideline needs of emerging ultrasound users’ 
groups, and to explore ways the document drafters can contribute to the development of sound 
guidelines for this diverse group. These are my key questions: 
 3
1) How should guidelines for emerging ultrasound applications be assessed? 
2) Is it appropriate to develop guidelines for these applications? 
3) If so, how can these guidelines best be constructed for validity and usability?  
Quest for Effective Medical Care 
The history of medicine recounts the eternal human quest for ways to combat disease and 
promote health and well-being. But disease processes are complex, and the quest for most 
effective, or “best,” diagnostic and treatment approaches has led medical investigators down 
myriad fruitless, even bizarre, pathways. Consider the practice of medicine in colonial America. 
Colony “doctors,” most of whom were educated entirely through apprenticeships, attacked their 
patients’ ails with copious blood-letting and all manner of strange and vile concoctions. In the 
1600s, “best practice” in the treatment of apparent blood diseases meant a prescription for 
tincture of charred toad. For madness there was St John’s wort, and for itching, patients were 
prescribed a brandy-turpentine-hog’s fat-fish worm cocktail.  From what may have been the only 
medical text book available in the Colonies, its author, Dr. Frances Packard, advised “For paines 
in ye Brest or Limmes; Weare a Wilde Catts skin on ye place grieved” (20).  
One might suspect that patients’ safety in early America was threatened by proximity to 
the very treatments doctors regarded as “best practices.”  In fact, some historians suggest that 
during the 1793 Yellow Fever epidemic, more people died from medical “care” than from the 
disease itself.   
For the first century of America’s history, colonial physicians had little more than lore 
and superstition on which to base their patient care decisions. “Evidence-based medicine” as we 
define it today was essentially nonexistent in those early years of American medicine. But in 
 4
1765 the quest to unravel the mysteries of disease sprouted academic roots with the opening of 
North America’s first medical school at the College of Philadelphia, now the University of 
Pennsylvania. King’s College, predecessor to Columbia University, quickly followed suit, 
conferring its first medical degree in 1770. In 1823 the University of Maryland built the first US 
teaching hospital, providing the fledgling American medical community with a formal research 
home where investigators could examine theories and grow evidence.  Evidence of most 
effective practices presumably provides clinicians with clear answers to how to best care for 
patients. 
Practice Variation and Patient Outcomes 
Unique insights are essential to the art of medicine. In fact, some of medicine’s most 
important advances have proceeded from individual flashes of intuition, only later supported by 
scientific evidence. An example is the germ theory of disease. In 1847, well before the germ 
theory was confirmed, Hungarian physician Ignac Semmelweis noted the much lower rate of 
“childbed fever” among women delivered by midwives, rather than by physicians who attended 
them with unwashed hands, immediately after performing autopsies. Based on his clinical 
observations and intuitive conclusions, Semmelweis established a “guideline” requiring 
physicians to wash their hands before deliveries, and in so doing, greatly reduced maternal 
morbidity and mortality. It was not until 1890 when the germ theory of disease was finally 
scientifically confirmed by Robert Koch.  
For the 19th and most of the 20th century, the practice of medicine relied more heavily on 
the common sense and powers of observation of the care giver than on formal evidence and 
broadly endorsed practice guidelines. Some of us still remember the family doctors of the 1950s 
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and 60s. Equipped with their black bags, physicians with their arcane knowledge were trusted by 
their patients as much for their sage judgment as for their medical educations. In fact, from 
formal education doctors learned about treatment options, but it was from their experiences that 
they built what were very personal “evidence bases” on which to found care decisions.  The 
doctor who saw one patient improve while following a particular regimen might generalize and 
apply that technique to all patients with the same complaint; a colleague in another community, 
informed by different experiences, might perceive “best” patient outcomes in response to another 
regimen. The practice of medicine varied among physicians according to their individual 
experiences and interpretations.  
Such variations in the practice of medicine seem charmingly Norman Rockwell, but, in 
fact, these disparities are associated with inconsistent, often poor, quality of care. According to 
Charlton, even with access to 21st century medicine, some clinicians “persist in old-fashioned 
and eccentric practices under the guise of ‘clinical freedom’” (Charlton 99-101).  Many other 
complex factors are associated with inconsistent care as well. Geographic variations have been 
reported, particularly with respect to prescription of drugs, and disparities in care have been 
reported associated with numerous social factors, including patients’ ethnicity, health provider, 
economic status, and gender. Schuster et al reviewed 48 articles that assessed the quality of 
preventive, acute, and chronic health care services in the United States. From their review these 
investigators concluded that among all populations “there are large gaps between the care people 
should receive and the care they do receive” (Schuster 517-563).  
Clearly “wrong,” or “inappropriate” care harms patients as occurs in the “wrong 
site/wrong procedure/wrong patient” scenario. “Too much” care in the form of unnecessary 
medications and services is also injurious, increasing the patient’s risks and side effects. A rising 
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number of unnecessary caesarean sections is increasing both maternal risk from surgical 
complications and fetal risk from sometimes-preterm delivery is an example of too much care. 
As conventional wisdom would predict, increased morbidity and mortality result from 
“too little” care, as when potentially beneficial diagnostic or therapeutic services are not offered.  
According to a Dartmouth Atlas Project Topic Brief on effective care, more than 68,000 people 
die each year from causes related to hypertension, but fewer than 65% of hypertensive patients 
receive recommended care.  Fewer than two thirds of older Americans receive the pneumonia 
vaccine, resulting in nearly 100,000 preventable deaths each year.  According to the Dartmouth 
report, “effective care is underused largely because our health care system lacks the means of 
supporting systematic compliance with treatment guidelines” (Dartmouth ).  
Nearly two centuries after the birth of medical education in the US, we shake our heads 
and smile at the 18th century colonial doctor’s leeches and poisons. But even with our more 
sophisticated knowledge, pharmacologies, and technologies, the practice of medicine remains 
imperfect. Clinicians still seek answers to questions as to how to provide best care for their 
patients, and patients still suffer at the hands of medical care givers. In fact, in 1991 the New 
England Journal of Medicine reported that, according to statistics gathered by a Harvard Medical 
Practice Study, an estimated 33,000-98,000 people die each year as a result of medical errors 
(10). That disturbing report catalyzed a widesweeping movement in the medical community to 
search out root causes for errors, to find ways to safeguard patients, and to optimize delivery of 




Rising Medical Costs 
Reducing unwarranted practice variation is driving a strong movement towards CPGs as 
tools for promoting patient welfare; another factor driving the guidelines movement is their 
hoped-for potential to improve the medical cost/benefit ratio and help contain the unsustainable 
rate of increase in health care costs.  From $294.3 billion  in 1969, in 2009 the cost of health care 
skyrocketed to $2.5 trillion, and higher spending levels are not associated with improved 
outcomes (Woolhandler 768). The Commonwealth Fund annually compares healthcare costs and 
outcomes of several countries. In its 2007 report, among Australia, Canada, France, Germany, 
Japan, Norway, Sweden, the United Kingdom, and the United States, in the US per capita health 
care costs at nearly 17 percent of the gross domestic product (GDP)  were the highest while life 
expectancy and infant mortality were the worst.   By reducing practice variation, can CPGs lead 
to better patient outcomes and more efficient use of medical resources? 
History of CPGs 
Guidelines have been used in medicine for centuries. Perhaps the earliest example in 
Western literature is the medical ethics guideline ascribed to Hippocrates. Thought to have been 
written around 400 BC, the “Hippocratic Oath” defined an ideal “Do no harm” practitioner-
patient relationship still relevant today. 
The modern guidelines movement began more than 50 years ago, and surged late in the 
20th century as concern grew regarding the rising cost of health care. According to Farmer, the 
rate of healthcare spending began accelerating in the 1960s when Medicaid/Medicare began 
offering extremely low cost care to poor and senior citizens. HMOs were created to try to regain 
control, but these managed care organizations failed to effectively slow spending.  
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Answers to the growing crisis were sought in outcomes research, and in 1987 William 
Roper, Chief of the Health Care Financing Administration (HCFA) launched a series of seminars 
focused on improving health care. One conclusion from Roper’s initiative was reported by 
researcher John Wennberg who demonstrated variations in healthcare, and healthcare costs, 
stemming from the way doctors were doing business.  Also as a result of the initiative, Robert 
Brook of the Rand Corporation developed criteria for judging appropriate performance of 
medical procedures. In 1988 Roper’s effectiveness initiative was formalized by HCFA, and the 
National Institutes of Health (NIH) and the National Center for Health Services Research 
(NCHSR) joined as partners to continue the outcomes research.  
It was in 1989 that guidelines became a real national focus. That year Congress charged 
the NCHSR, eventually renamed the Agency for Healthcare Research and Quality (AHRQ), with 
leading in the task of developing and evaluating CPGs. Interest in evidence-based guidelines was 
evolving, and in 1989 the Institute of Medicine (IOM) launched an initiative to evaluate the 
quality of CPGs and plan ways to advance the art of guideline development. CPGs were 
formalized as a genre in 1990 when the IOM formally defined them as “systematically developed 
statements to assist practitioners and patients in choosing appropriate health care for specific 
clinical conditions” (Field 38). 
 
The Role of CPGs in Reducing Practice Variation 
According to a report from the Agency for Healthcare Research and Quality (AHRQ), a 
research arm of the US Department of Health and Human Services, “Scientific studies have 
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proven that following best practice guidelines reduces suffering and patient mortality, while 
improving quality of life and clinical outcomes” (??). 
Guyatt et al acknowledge that practice should be guided by findings reported in the 
literature, but they maintain that for many practitioners the medical literature is inaccessible. 
“Researchers studying the literature must accurately interpret a diverse range of journal articles 
and analyze the overall statistical findings, as well as the circumstances unique to each included 
study” (from AHRP website http://www.ahrq.gov/clinic/epc/qgapfact.htm). 
Compounding the difficulty for individuals attempting to stay abreast of the literature, its 
volume is staggering, and increasing. According to Guyatt, “every few years the literature 
doubles in size, and every year we seem to have less time to weigh it,1” (Guyatt or Durack – 
check this reference - )  Especially as technological innovation explodes and research into 
application outcomes flourishes, it becomes increasingly difficult for clinicians to review all 
available literature on a topic. 
As long ago as 1951 Garland identified the problem for radiologists: “The expanding 
literature on radiology threatens to engulf the serious worker. Since radiology embraces the 
diagnostic and therapeutic applications of radiant energy in the entire field of medicine, this 
expansion is both understandable and inevitable” (??).  
Garland’s 1951 predictions were correct. In fact, American diagnostic radiology 
researchers published 468 papers in 1960 and nearly 3000 in 1984 (Chew 1055); between 1990 
and 2005 more than 7500 original articles were published in the journal of the Radiological 
Society of North America alone (Arrive 330). Rapidly accumulating medical research data is, 
indeed, expanding the literature to such a volume that clinicians can no longer rely on personal 
reading to keep them abreast of all research findings relevant to their areas of practice. To further 
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complicate the clinician’s task of digesting the literature, conclusions of different studies often 
conflict.”  
One broadly supported solution to the problems with the literature (2 Goolsby) is to look 
to teams of experts to review all possible care options, weigh the evidence for and against each, 
and, based on the evidence, develop evidence-based care recommendations  communicated 
through clinical practice guidelines (CPGs),  Battista 7:  “CPGs offer the potential to reduce 
uncertainty attributable to suboptimal decision-making due to unfamiliarity with relevant 
scientific knowledge” (provide source info at end of passage). 
Across the board, the health care industry is focused on standards and guidelines as tools 
for promoting patient welfare. For example, some commercial health plan programs, or “3rd party 
payers,” have instituted strict quality measures of “privileging” and “site accreditation” as 
conditions for reimbursement for imaging services. DC Levin and VM Rao describe Blue Cross 
Blue Shield programs, and they report how those quality requirements have affected the delivery 
of health care. According to these authors, by reimbursing for only those services provided by 
practitioners with specific training, third party payers have helped reduce the number of studies 
completed by low-quality providers; by requiring site accreditation as a condition for payment, 
these commercial health plan providers are raising the bar on facility quality standards.  
At issue: do CPGs work? How do guideline developers write these documents to be 
effective? And how can potential users assess the likeliness of reliability of recommendations? 
Introduction to Ultrasound Guidelines and Emerging Applications 
In ultrasound, as in other areas of medicine, practice guidelines are developed and 
regularly revised to articulate the community’s agreed-upon minimum standards of care. 
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Currently the American Institute of Ultrasound in Medicine (AIUM) publishes 24 practice 
guidelines developed by its Clinical Standards Committee (CSC), most guidelines in 
collaboration with one or more other professional organizations. Writing and revising guidelines 
even for fairly standard practices is complicated and strongly rhetorical. Guidelines must be 
carefully worded to protect patients, protect doctors and other caregivers, satisfy regulating 
agencies like the Joint Commission, and satisfy third party payers. Complex collective voice, 
complex audience, complex purpose—these and other elements add up to complex content 
development and technical communication challenges.  
While many medical guidelines address specific disorders, most current ultrasound 
guidelines outline performance and training standards for imaging a particular body structure, or 
group of structures. Traditionally, ultrasound examinations are performed in designated 
ultrasound laboratories by ultrasound imaging specialists. Outpatients travel to these facilities, 
and patients already receiving care in a facility are moved to the ultrasound lab for the exam. But 
the practice of ultrasound is changing; traditional body part imaging is no longer the only 
application for this very user-friendly technology, and the ultrasound department with its 
specialized clinicians is no longer its only setting. Because ultrasound is free of ionizing 
radiation, highly portable, and relatively inexpensive, medical caregivers from specialties outside 
traditional imaging boundaries are picking up transducers and trying them out for an expanding 
array of new uses, many at the “point of care” in labor and intensive care units, emergency 
departments, and surgical suites. Emergency physicians examining critically injured patients are 
using ultrasound for a quick look for internal bleeding; nurses are using it to guide insertion of 
PICC lines; anesthesiologists are looking with ultrasound to localize a nerve for injection. And 
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that short list covers only a few of the possible new uses. Traditional imaging ultrasound is being 
joined by an explosion of emerging applications.  
The characteristic that distinguishes an application as “emerging” generally falls into one 
of these categories: use of ultrasound to examine structures not traditionally evaluated with 
ultrasound; or use of the technology to perform traditional imaging tasks in nontraditional 
settings, by practitioners whose primary specialty is not ultrasound imaging, or with a more 
limited scope. Some characteristics of these emerging applications are controversial and may 
pose challenges to achieving consensual guidelines. Of the features that characterize emerging 
applications, the two that may prove most contentious relate to exam scope and practitioner 
provider. To protect patients from inconsistent, insufficient care, the standards of the traditional 
sonography community require performance of "complete" examinations, and only by 
credentialed sonographers or physicians as described by existing CPGs. Any guideline verbiage 
that is perceived to dilute these standards will likely meet with strong opposition. 
Two major factors are driving interest in development of guidelines for emerging users of 
ultrasound. First, the number of new users is large and growing, and both users and patients 
would likely benefit from guidelines outlining the safest, most effective techniques for their new 
applications. Second, the current medical climate and the huge push for improved patient safety 
is promoting guidelines and standards as a means to reduce errors and improve effectiveness of 
medical care decisions. Exploring the task of developing practice guidelines for emerging users 
of ultrasound is timely and important both for practitioners and for their patients.  
In Chapter Two, I review the literature review that describes the format and attributes that 
characterize clinical practice guidelines. I explore the challenges inherent in writing high quality 
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guidelines with a focus on the special challenges associated with emerging point-of-care 
ultrasound applications. 
In Chapter Three, “Methodology,” I discuss the Appraisal of Guidelines Research in 
Evaluation (AGREE) instrument as a tool for assessing writing practices that affect the validity 
and usability of a docment. AGREE is a validated and well accepted tool, but it is not entirely 
appropriate for assessing guidelines for emerging ultrasound applications or for other guidelines 
of similar purpose. Adjusting AGREE according to needs I assigned to emerging users’ 
guidelines, I developed an assessment tool to use for these documents. 
In Chapter Four I present my analyses of six clinical practice guidelines that address 
various ultrasound applications. Using the rubric developed through the process described in 
Chapter Three, I assess text components of these documents and rate how effectively each one 
promotes guideline validity and usability.  Although I assign a score to attributes and to each 
document overall, the primary purpose of my assessments is to identify writing practices that 
weaken guidelines and to highlight practices that make the documents strong.  With this study I 
evaluate features and writing challenges fundamental to CPGs, but I direct special focus toward 
those attributes that may prove most important, and most challenging, for developers of 
guidelines for emerging ultrasound applications.  
In Chapter Five, I describe conclusions based on the literature and on my experiment 
with guideline document assessment. Applying the conclusions I reached with respect to 
assessments, I developed a template for drafting emerging users’ guidelines. Finally, combining 
the assessment tool described in Chapter Three with the template descried in Chapter Five, I 
provide a CPG Quality Assessment and Construction Toolkit (Appendix B). I believe findings 
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and conclusions from this thesis may be used by guideline drafters to enhance the quality of 
CPGs for emerging users.  
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CHAPTER TWO: LITERATURE REVIEW 
The rapid increase in the number of CPGs published during the past several years gives 
testament to people’s belief in their potential to reduce practice variation. But guideline 
development as a discipline is scrutinizing itself. In their seminal 1993 article, Grimshaw and 
Russell state that “the quality of published guidelines is variable” (Developing 243).  As a result 
of this concern, there is growing interest in ways to assess guidelines and to apply quality 
measures prospectively during the development process. In this literature review, I discuss the 
basic format and attributes that characterize CPGs, and I explore the demands inherent in writing 
high quality guidelines, with a focus on the special challenges associated with emerging point-of-
care ultrasound applications. 
Many CPG development groups have looked at ways to evaluate guideline quality. Some 
groups focus on topics related to gathering and grading evidence; others examine the method 
used to formulate recommendations; still others discuss strategies for implementation. I reviewed 
those topics, but with a focus on the role of the writer in effectively conveying the nature of 
those processes and findings. Next, I reviewed the literature that differentiates guidelines 
according to their purposes, and examined how their different functions might affect document 
characteristics. I gave special consideration to the guideline needs for emerging ultrasound 
applications.  
Using University of Central Florida online library resources, I first sought relevant 
sources through a Medline search using these key words and key word phrases: clinical practice 
guidelines, practice guidelines, medical guidelines, guidelines, performance guidelines, history 
of guidelines, validity, collaboration, collaborative techniques. Using the same key words and 
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phrases, I searched the Internet using Google and Google Scholar. Some additional sources were 
identified from among bibliographic references in selected articles, and others were 
recommended by a physician colleague. To identify primary guideline documents for analysis, I 
searched the Internet using key words “medical professional organizations,” and then selected 
and downloaded CPGs from organizations’ websites. An e-mail from a patient is included with 
her permission. 
The Rhetorical Challenge 
Compelling considerations underlie the writing challenges inherent in this specialized 
genre of medical literature, and recommendations conveyed by guidelines bear significant 
clinical, professional, and economic impact. Health outcomes are most important, but the cost of 
suggested care must be taken into account when advocating care practices, as well as the 
obligations guideline recommendations impose upon clinician’s resources. In a way, CPGs 
represent a negotiated understanding between all members of the audience, and the audiences for 
these highly consequential documents are multiple and complex. As an example, the primary 
audience for an obstetrical ultrasound guideline includes sonographers and sonologists who 
perform the exam according to the guideline-recommended protocol. Then to this already-
diverse group, with its range of background experiences, add the physicians, physician assistants, 
and midwives who refer patients for ultrasounds based on indications listed in guidelines, and the 
more distant but still real audience of patients, insurers, legislators, and others.  
Each of these reader groups views CPGs through a lens of special interest. For example, 
according to Grimshaw, the costs of recommended care may be of particular concern to third 
party payers. In fact, for major purchasers of health care, like the Centers for Medicare and 
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Medicaid Services (CMS), cost effectiveness is a critical issue. With the cost of medical care 
rising at a rate that exceeds inflation and the gross domestic product, these CPG purchasers will 
likely examine guidelines for evidence of clinical and cost effectiveness of recommended care. 
Across the board the health care industry is focused on standards and guidelines as tools 
for promoting patient welfare. For example, some commercial health plan programs, or “third 
party payers,” only reimburse for imaging services performed by providers who are identified 
through accreditation programs of professional organizations like the American Institute of 
Ultrasound in Medicine (AIUM) as adhering to high standards of patient care. Since to be 
designated as “accredited,” clinical groups must agree to practice according to specific 
guidelines, CPG preferences of these large insurers bear significant implications for health care 
providers.  
There is evidence of positive outcomes from insurers’ support of guideline-based 
practices. Levin and Rao describe Blue Cross Blue Shield programs, reporting how their quality 
requirements have affected the delivery of health care. According to these authors, by 
reimbursing for only those services delivered by practitioners with specific training, third party 
payers have helped reduce the number of studies completed by low-quality providers (535). By 
requiring site accreditation and adherence to particular guidelines as a condition for payment, 
these commercial health plan providers are raising the bar on facility quality standards.  And 
movement toward accreditation and encouraging practice according to guidelines as a condition 
for compensation will continue. United Healthcare (UHC), one of the largest private insurance 
companies in the US, declares on its website that it now reimburses only accredited providers for 
performance of Computed Tomography, Magnetic Resonance Imaging, and Positron Emission 
Tomography, and some cardiology imaging procedures, and they are considering “future 
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application to other ultrasound services.” UHC’s website reports that by January 1, 2012, 
Medicare will also require provider accreditation as a condition for payment of some imaging 
fees. 
Clinicians, insurers, and legislators have interests in reading CPGs, and some patients are 
reading medical literature, including practice guidelines, as well. Just a few years ago Americans 
regarded the principles of medicine as mysterious, largely inscrutable concepts; physicians with 
their secret knowledge were revered and rarely questioned. But today, thanks to the World Wide 
Web, a staggering volume of medical information (and misinformation) is readily available to 
anyone with access to the internet. Any lay person can google “H1N1” and reach roughly 
132,000,000 relevant sites. The Internet surfer in a small town in Alaska need only type in 
keyword “headache” to learn about headache symptoms, diagnosis, and treatment from some 
26,700,000 sites. 
The cyber-information explosion is making lay diagnosticians of us all, and contributing 
to a paradigm shift in the clinician-patient relationship. For as Frederick Douglass learned, 
information access is empowering. In his autobiography, Douglass relates his master’s 
opposition to his wife’s teaching the young slave to read: “If you teach [Douglass] how to read, 
there would be no keeping him. It would forever unfit him to be a slave… . It would make him 
discontented and unhappy” (1071). As Douglass discovered, his master was right: information 
access leads to questioning. 
Indeed, today’s more informed patients are much more likely than their grandparents to 
question their care providers, and 21st century patients’ outcomes expectations are greater. 
Americans witnessing the medical innovations and improved outcomes of the last few years have 
come to expect a lot from their medical care and care providers. In the following e-mail, a patient 
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recounts her family’s difficult experience at the birth of her child, and conveys her frustration 
with failure of prenatal ultrasound clinicians to identify her baby’s serious structural defect. The 
patient specifically references prenatal ultrasound guideline recommendations that were not 
followed during her exam. 
2/26/2010 
 
My son was born in December 2007 with Bladder Exstrophy.  This condition went 
undetected prenatally by ultrasound.  I am a nurse and have studied my son's ultrasounds 
(5 total), radiology reports, and fetal anatomy criteria to be met by ultrasound.   
… 
 Our radiology report does not document umbilical cord insertion site, the route of the 
arteries to the umbilical cord, a definitive abdominal wall, emptying and filling of the 
bladder, or pelvic bone structure.  The radiologist did document that the bladder could not 
be seen but later amended the report saying that the structure must be very small.  
 
Our obstetrician never questioned these reports nor mentioned any concerns to me or my 
husband.   
 
The only change to the outcome of our situation would have been preparation for birth, 
preparation financially, and the ability to shield our then 8 year old daughter from a 
frightening situation.  Our son was born vaginally, in a rural hospital to staff who had 
never seen this condition, ill equipped to care for our baby.  He was transported to 
Jacksonville, where we were questioned on several occasions as to why we did not 
receive prenatal care.   
 
That day quickly turned from one of the most joyous days of my life to a nightmare.  God 
has blessed us, and our son is doing great.  He will have future surgeries and has endured 
four to date.  My fear is that others will be faced with a similar situation, when it can be 
prevented.   
 
Parents should have the opportunity to arrange for their birth to take place in a facility 
equipped to handle this type of case and the proper birthing method.  They should have 
the opportunity to prepare themselves financially for this situation.  We have incurred 
medical costs that we will not soon overcome.  They should have the opportunity to learn 
about this birth defect and know what to expect after birth.  This condition requires a 
progressive approach, babies will endure several surgeries, parents need to be trained in 
what they can do to help their child heal. They should have the opportunity to prepare 
their families, other siblings and grandparents, it is devastating to not know why no one 
can see or hold the long awaited bundle of joy.  
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My goal is to raise awareness in the medical community and the need for continuing 
education to keep technicians, radiologists and obstetricians current and informed in 
medical advances along with proper diagnosis given specific tests outcomes.   
 
Clearly audiences for guidelines include a wide range of readers, from specialized 
clinicians to patients with no medical background, and these readers are often strongly vested in 
their perceptions of the recommendations and outcomes described in CPGs. To meet the 
rhetorical responsibilities imposed by these factors, developers of all types of clinical practice 
guidelines are charged with wording information accurately and in such a way as to be 
understood concordantly by all members of the audience This is no simple task, for as Richards 
and Ogden note in “The Meaning of Meaning,” “Words… are a very imperfect means of 
communication” (1277). Particularly in light of potential ramifications of misinterpretation, it 
may not be sufficient for content experts to simply state the facts. As Kenneth Burke observed, 
“We can safely take it for granted that no one’s ‘personal equations’ are quite identical with 
anyone else’s” (1345). 
Such ambiguity as Burke describes challenges interpretation of the most fundamental 
descriptor of clinical practice guidelines, the term that is often regarded as synonymous with 
high quality: “evidence-based.” McAlister et al observe that this seemingly explicit term may 
carry different meanings for guideline developers than for clinicians. To clinicians, ”evidence-
based” may seem to imply the high quality of RCTs while for guideline developers the term 
strictly means that recommendations are based on evidence that was derived from systematic 
search and evaluated as to strength. This important distinction illustrates the difficulty of writing 
meaningful, unambiguous, high quality guidelines. 
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Guideline Attributes 
In drafting these complex documents, technical communicators with their specialized 
wordsmithing skills can provide valuable assistance to the content expert members of guideline 
development committees. In fact, the overall quality of a guideline depends on both its ideas and 
its documentation. Grimshaw and Russell frame the broad concept of guideline development, 
intertwining the process of developing content with the task of drafting the final, implementable 
document. In the first in their series of articles, the authors identify and define nine fundamental 
attributes of CPG quality (Developing Scientifically 245): 
 Validity 
 Reproducibility  
 Reliability 
 Representative development  
 Clinical applicability  
 Clinical flexibility  
 Clarity 
 Meticulous documentation 
 Scheduled review 
Of these nine attributes described by Grimshaw, two directly relate to authors’ technical 
task of document construction: clarity and meticulous documentation. According to Grimshaw 
and Russell, document clarity depends on accurate, unambiguous presentation of information in 
a format designed for easy access (Developing Scientifically 245). Meticulous documentation 
requires accurate reporting of all details of guideline development. 
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Two other attributes relate to the functional application of guideline recommendations: 
clinical applicability and clinical flexibility. The authors assert that guidelines have clinical 
applicability if the recommendations suit the defined patient population. The attribute of clinical 
flexibility provides leeway and guidance for clinical judgment to override recommendations. The 
attribute of scheduled review ensures that recommendations are based on current evidence and 
will be updated as evidence changes. 
Grimshaw and Russell characterize “validity” as a more global attribute than the others, 
and of the most critical importance to guideline quality. It is also likely the attribute that will 
prove the most challenging for developers of emerging users’ guidelines to implement. So what 
does it mean for a guideline to be “valid”? How is that quality defined? According to Dorland’s 
Illustrated Medical Dictionary, validity is “the extent to which a measurement, test, or study 
measures what it purports to measure” (“Validity,” def. 1). The Agency for Healthcare Research 
and Quality (AHRQ) Glossary of Terms located on their website offers a similar definition, 
stating that validity is determined by “whether a test or technique actually measures what it is 
intended to measure.” The AHRQ applies that general definition with respect to guidelines, tying 
validity to expected health and cost outcomes. Similarly, in their 1995 article, Grimshaw et al 
specify that the validity of guidelines is measured by their effect on patient outcomes and 
resource utilization. They define guidelines as “valid if, when followed, they lead to 
improvement in patient outcome at acceptable costs” (Implementing 61).  
According to Grimshaw and Russell , the quality of validity depends on AHRQ’a three 
remaining attributes of reproducibility, reliability, and representative development. They say that 
reproducibility means a guideline’s recommendations should seem appropriate to the evidence 
base as interpreted by various groups; reliability assures that groups other than the guideline 
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drafters will be likely to apply the guideline similarly and under similar circumstances. The 
authors assert that to promote these two conditions of reproducibility and reliability, the 
guideline development group must include representatives of all relevant interests.  
Grimshaw’s “attributes” inform the task of capturing validity in these documents. 
According to the AHRQ, three factors constitute the main influences on guideline validity: 1) the 
strength of the evidence on which recommendations are based, 2) the method used to evaluate 
the evidence, and 3) the relationship between the force of recommendations and the strength of 
the supporting evidence. In the next sections I review the literature related to each of these three 
influences, and I discuss the dual and complimentary roles of content experts and technical 
communicators in addressing these elements. 
Characterizing the Evidence 
Various authors discuss factors that affect the quality and strength of evidence. Several 
authors stress the importance of a literature review as a basis for evidence quality. Drafters’ 
meticulous reporting of the literature search and review process enhances the document’s 
validity by communicating to users the degree to which they can rely on the guideline’s 
recommendations. Through a formal, objective literature review, evidence relevant to a 
guideline’s topic is located and considered. Grimshaw advises that guidelines developed 
“without a lit review may be biased towards reinforcing current practice rather than promoting 
evidence-based practice” (Developing Scientifically 246). In another article Grimshaw warns of 
the potential for bias when formal systematic literature reviews are absent from the development 
process and recommendations are based entirely on the literature familiar to and supplemented 
by the opinions of the committee members. According to Grimshaw, such recommendations 
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“often lag behind available evidence and may reflect individual enthusiasms rather than the 
knowledge base” (Developing and Implementing 61). 
Shekelle et al provide details appropriate to this report item. In the second article of a 
series on guideline development, these authors outline an evidence search method, beginning 
with the step of consulting an up-to-date systematic review on the guideline topic. In the absence 
of an available systematic review, they describe using formal computer search strategies to locate 
relevant, appropriately designed studies. 
The literature suggests that guideline drafters promote validity by accurately 
characterizing the strength of each piece of evidence that comprises a CPG’s evidence base. That 
strength of evidence, according to the Training Manual for The AGREE Collaboration Appraisal 
of Research and Evaluation (AGREE) Instrument, is related to “the extent to which all aspects of 
a study’s design and conduct can be shown to protect against systematic bias, non-systematic 
bias, and inferential error” (62).  
Guideline drafters transparently report the risk of bias inherent in evidence by properly 
characterizing its study design and applicability. According to the ranking scheme of the AHRQ, 
evidence least vulnerable to bias is that which is obtained from systematic reviews and meta-
analyses of randomized controlled trials. Since these studies include large numbers of 
participants, the effects of individual-specific, unintended variables are minimized, and 
proceeding results are highly reliable. Also highly reliable, but one step down because of lesser 
numbers, are randomized controlled trials. Vulnerability to bias increases for evidence from the 
next category of studies, non-randomized intervention studies, and increases even more with 
observational and non-experimental studies. The AHRQ ranks expert opinion as the lowest 
quality of evidence with the greatest risk of bias. Other guideline developers rank evidence 
 25
quality similarly, generally regarding the strength of evidence as inversely related to the 
possibility of study bias and directly related to the quality of the study design and 
implementation.  
McAlister et al identify clinical relevance as another factor that affects CPG validity. 
According to McAlister et al, even guideline recommendations based on “high quality” evidence 
from internally valid RCTs are of less than “high” quality if clinically irrelevant or not directly 
applicable to the target population. These authors analyzed bibliographies of guidelines for 
treatment of type 2 diabetes mellitus. Of 15 “evidence-based” guidelines, there was very little 
concordance of reference selection, and the study cited most frequently among the guidelines’ 
references did not actually include patients with type 2 diabetes mellitus. To define the quality of 
their evidence bases more effectively, these authors advocate grading guidelines using schemes 
that take into account the clinical relevance and applicability of recommendations (e250).  
Drafters’ meticulous reporting of the literature search and review process enhances the 
document’s validity by communicating to users the degree to which they can rely on the 
guideline’s recommendations. In a description of the process, Shekelle et al provide details 
appropriate to this report item. In the second article of a series on guideline development, these 
authors outline an evidence search method, beginning with the step of consulting an up-to-date 
systematic review on the guideline topic. In the absence of an available systematic review, they 
describe using formal computer search strategies to locate relevant, appropriately designed 
studies.  
 The authors describe how selected evidence may be rated, interpreted, and translated into 
recommendations of various strengths, depending on the quality of their evidence base.   
According to Shekelle et al “Recommendations based solely on clinical judgment and experience 
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are likely to be more susceptible to bias and self interest.” When expert opinion is incorporated, 
“the process needs to be made as explicit as possible” (Shekelle 595). Recommendation grades 
convey with what confidence guideline developers level of confidence that following the 
recommendation will lead to the predicted outcome.  
Grimshaw and Russell discuss the relationship between the evidence and validity, and 
they rate the likelihood of various evidence bases leading to valid guidelines. From formal meta-
analyses and graded systematic reviews, they predict “high” likelihood; with ungraded 
systematic reviews they predict “medium”; from unsystematic reviews or from expert opinion 
they predict “low” likelihood of guideline scientific validity.  At issue in terms of bias and 
evidence synthesis: expert opinion alone tends to reinforce existing practices. Objective 
conclusions depend on unbiased consideration and interpretation of all possible solutions and 
outcomes (Developing Scientifically 245). 
The tasks of grading the evidence according to its risk for bias, and rating 
recommendations according to assigned strength are simplified by many groups by symbolically 
encoding the information. Different organizations use varying codes, but as an example, 
following is the classification scheme reported by Shekelle et al (595):  
Category of evidence 
 
Ia-evidence for meta-analysis of randomised controlled trials 
Ib-evidence from at least one randomized controlled trial 
IIa-evidence from at least one controlled study without randomissation 
IIb-evidence from at least one other type of quasi-experimental study 
III-evidence from non-experimental descriptive studies, such as comparative studies, 
correlation studies, and case-control studies 
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IV-evidence from expert committee reports or opinions or clinical experience of 
respected authorities, or both. 
Presenting Recommendations 
Strength of recommendations 
 
A-directly based on category I evidence 
B-directly based on category II evidence or extrapolated recommendation from category I 
evidence 
C-directly based on category III evidence or exrrapolated recommendation from category 
I or II evidence 
D-directly based on category IV evidence or extrapolated recommendation from category 
I, II or III evidence 
Inevitably evidence is viewed through the lens of cultural values, which helps explain 
variation in recommendations among different guidelines developed for a single application. For 
example, looking at cholesterol management guidelines, Battista et al note differences in the 
scopes between those of the United States and Canada. These authors contend that the difference 
reflects “a cultural preference for greater caution in Canada” (Uneasy Juncture 878). The 
perspective of Battista et al highlights the rhetorical task inherent in writing guidelines. The 
authors illuminate the challenge of drafting guidelines that base recommendations on evidence 
but stop short of stripping away the art of physician judgment informed by physician-patient 
interaction (Between 385). 
Ultimately the greatest impact on patient care comes from a guideline’s recommendations, 
so the wording of recommendations is arguably the most important part of the drafters’ task, and 
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it may be the most difficult. It is certainly the most rhetorical guideline draft task, as the meaning 
of recommendations emerges from the person reading it. The CDC identifies 3 audiences for its 
guidelines: patients, clinicians, and policymakers, and sets explicit communication goals for 
each:  
For patients, guideline categories convey desirability of the course of action.  Category I 
means “Most people in the patient’s situation would want the recommended course of action and 
only a small proportion would not.” Category II means “Most people in the patient’s situation 
would want the recommended course of action, but some may not” (US CDC 17). 
To clinicians, categories convey level of clinical imperative for a course of action: 
Category I means “Most patients should receive the recommended course of action.” Category II 
means “Different choices will be appropriate for different patients and clinicians must help 
patients arrive at management decisions consistent with her or his values and preferences” (US 
CDC 17). 
For policymakers, categories indicate level of mandate. According to the CDC, Category 
I recommendations “may be considered for policy in many situations.” Category II 
recommendations will require “substantial debate” to be translated into policy (US CDC 17) 
The strength of a recommendation is generally linked to the quality of the evidence, with 
high quality evidence leading to strong recommendations.  For Category I recommendations, 
strongly directive verbs, like “do” or “do not” are used; for Category II recommendations, verbs 
like “consider” are used (US CDC 18). 
Guideline drafters explicitly select verbs to convey the strength of each recommendation.  
Generally, the expressed intent of ultrasound practice guidelines is to provide flexible 
guidance. From the preamble to all AIUM practice guidelines: 
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Practice guidelines of the AIUM are intended to provide the medical ultrasound 
community with guidelines for the performance and recording of high-quality ultrasound 
examinations. The guidelines reflect what the AIUM considers the minimum criteria for a 
complete examination in each area but are not intended to establish a legal standard of 
care. AIUM-accredited practices are expected to generally follow the guidelines with 
recognition that deviations from these guidelines will be needed in some cases, 
depending on patient needs and available equipment. Practices are encouraged to go 
beyond the guidelines to provide additional service and information as needed. 
 
But although the overall tone of ultrasound practice guidelines implies flexibility, these 
are complex documents that, in fact, contain language from all categories, or levels, of 
recommendations. From the AIUM Practice Guideline for the Performance of the 
Musculoskeletal Ultrasound Examination, IV. Supervision and Interpretation of Ultrasound 
Examinations: 
“A physician must be available for consultation with the sonographer on a case-by-case 
basis” (‘standard’ language). 
“Ideally, the physician should be on-site and available to participate actively in the 
ultrasound examination when required. It is recognized, however, that geographic 
realities may not permit the presence of an on-site physician in all locations.” (‘guideline’ 
language).  
“Throughout the examination of the rotator cuff, the cuff should be compressed to detect 
nonretracted tears” (‘guideline’ language). 
“In the evaluation of rotator cuff tears, comparison with the contralateral side may be 
useful” (‘option’ language). 
If guidelines are to help clinicians and patients make informed decisions, they must meet 
the basic standards of technical documents: Considering the audience, guideline drafters must 
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present well-informed, unbiased recommendations in using clear, unambiguous language, using 
a user-friendly format.   
 
But other factors affect recommendation strength as well. For example, during the Avian 
flu epidemic, as soon as an effective treatment was discovered, a strong recommendation was 
issued to provide that treatment to patients. No randomized controlled trial data with high quality 
data supported the recommendation, but the risk of fatality and of spread of the disease was great. 
Delaying treatment until it could be proven effective was not practical, and randomized control 
trials would have been unconscionable.  
Emerging Users and Appropriateness  
When new approaches enter the patient care arena, they have not yet generated much 
evidence from which to develop recommendations, and guideline development for evolving 
ultrasound applications is controversial. The evidence problem associated with writing CPGs for 
emerging applications was addressed by the 1993 Canadian Workshop on Clinical Practice 
Guidelines. A summary of this group’s proceedings reports workshop participants’ discussions 
of challenges and best approaches to developing clinical practice guidelines. One issue raised at 
the workshop was the problem of writing guideline statements for newly evolving practices. 
Although some members of the group did not support development of guidelines when evidence 
was sparse, others felt that “scientific uncertainty” should not impede CPG development. 
Attendees concluded that even when little relevant evidence exists and definitive statements are 
not possible, guidelines can be written based on expert opinion, provided that the quality of 
supporting evidence is properly characterized. To enhance validity of such guidelines, in the 
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absence of substantial evidence these authors recommend a thorough explanation of methods, 
with revisions as necessary to develop growing knowledge (1715-1719). 
Most importantly, the document must provide evidence that every reasonable effort was 
made to overcome bias. When recommendations proceed largely or entirely on expert opinion, 
validity must be established through these features: 
 Guidelines development committee composition to include a broad spectrum of 
perspectives 
 A well-documented, high quality, transparent collaborative process 
 Accurate characterization of evidence and recommendations 
 A built in method of gathering evidence prospectively to validate recommendations or to 
inform revisions 
 

















CHAPTER THREE: METHODOLOGY 
In this chapter I present the criteria I used to analyze and rate technical writing attributes 
of several current CPGs. The quality of these attributes influences the accuracy and readability of 
guideline documents, and so affects their respective values as clinical tools. For a CPG to be 
valuable to clinicians, and ultimately to patients, it must convey accurately characterized 
information in clear, unambiguous language in a format and style that makes the information 
accessible to the user. I propose that when a guideline meets the criteria I set forth in this chapter, 
the guideline writing quality promotes the users’ needs for validity and usability. it 1) meets the 
definition of validity and 2) it meets usability standards. 
To begin, I discuss the background and the writing-specific features of Appraisal of 
Guidelines Research in Evaluation (AGREE) instrument. Because of its demonstrated value and 
its suitability to assessing technical communication, AGREE served as the foundation for the 
rubric I developed.   Next I describe variations in purpose and functionality among guidelines, 
and I examine a guideline’s functional “category” as a crucial factor in the quality equation. 
Finally, I advance a guideline assessment rubric I developed by combining selected items from 
AGREE with additional criteria related to the nature of each category.  In the chapter that 
follows, I use this new tool to evaluate the quality of several CPGs. 
The AGREE instrument 
In the mid 1990s, the EU Biomedicine and Health Research Programme sponsored an 
international meeting of researchers to consider the problem of variation in the quality of CPGs. 
Included among the participants were representatives from Canada, Denmark, England, Finland, 
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France, Germany, Italy, Netherlands, New Zealand, Spain, Scotland, Switzerland, and the United 
States. These researchers collaboratively developed an instrument designed for use both as a tool 
for assessing the quality of existing CPGs and as a guide to a “harmonious” development process.  
Called the Appraisal of Guidelines Research an Evaluation (AGREE), the instrument evaluates 
the quality of reporting found in CPG documents, and it assesses some aspects of the guideline 
development process. The AGREE tool was extensively field-tested and validated through 
application to a random sample of guidelines. AGREE is now looked to as a reference by 
guideline developers all over the world. 
AGREE provides structured assessments for six guideline “quality domains” identified 
by its developers as fundamental to guideline quality. The quality domains include guidelines’ 1) 
Scope and purpose, 2) Stakeholder involvement, 3) Rigour of development, 4) Clarity and 
presentation, 5) Application, and 6) Editorial independence. Within each quality domain are 
items that contribute to the domain’s objective. A total of 23 items comprise the AGREE 
instrument.  
Domain 1: Scope and Purpose 
The first quality domain is that of “Scope and Purpose.” According to the criteria 
outlined by AGREE, to justify the resources invested in development of a particular guideline, 
the need for the guideline should be conveyed in its introduction. Also in the introduction, the 
overall objectives of the guideline, the core clinical questions it will address, and the guideline’s 
target patients should be stated. It is crucial for these introductory details of scope and purpose to 
be clearly and unambiguously defined because they will direct the guideline development 
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research and focus guideline developers’ recommendations. To meet AGREE’s scope and 
purpose criteria: 
Item 1. Statements should provide a rationale for the guideline, and address its expected 
impact, i.e., improvement of a particular problem. Content should identify the guideline’s 
expected result, target population, and category of care.  
Item 2. The fundamental clinical questions, or interrogative statements, should be 
detailed, and they should provide operational links to the key recommendations. Content should 
define the intervention of interest, and when more than one intervention is considered, the 
options should be compared. The guideline should also describe for whom the interventions are 
being considered, the expected outcomes, and the treatment setting.  
Item 3. Relevant characteristics of the target population should be reported, and 
characteristics that would exclude some patients should be identified.  
Domain 2: Stakeholder Involvement 
AGREE’s second quality domain, “Stakeholder involvement,” assesses how effectively a 
guideline development group represents the perspectives of patients and other individuals and 
groups whose interests will be directly affected by the guideline. Underlying this domain’s 
concern is dominance of special interests, and the potential for a biased development process that 
could undermine the ethics and practicality of guideline application. For example, fetal 
echocardiographic examinations are performed and interpreted by members of several different 
clinical groups, including pediatric cardiologists, maternal fetal medicine specialists, and 
specially trained obstetricians. If a guideline for performing fetal echoes is developed by a 
committee that does not include members of one of those professional groups, the guideline may 
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be weakened by omission of the group’s particular training pathway or its perspective on 
examination components. If the insurer’s perspective is not considered, costs associated with 
guideline recommendations could become contentious. If patients’ preferences are not 
considered, there may be poor compliance with recommendations. To meet AGREE’s 
stakeholder involvement criteria: 
Item 6.  Target user groups should be well defined to include all potentially qualified 
providers, and the purpose of the guideline should be identified.  
Domain 3: Rigor of Development 
Quality Domain 3, “Rigor of Development,” evaluates a guideline’s scientific soundness. 
This domain deals not with the intrinsic quality of the evidence, but, rather, with the methods 
through which it is selected, interpreted, and translated into recommendations.  The risk of bias 
and of perpetuating outdated practices is reduced when guideline developers methodically search 
the literature for relevant evidence sources, and then narrow the number of sources using 
objective criteria, finally formulating recommendations based on an analysis of the evidence. 
Thorough, accurate reporting of the development process is fundamental to establishing 
guideline validity, and regular updating is essential to keeping recommendations aligned with 
current evidence. To meet AGREE’s criteria for developmental rigor: 
Item 8.  Explicit definition of inclusion/exclusion criteria for evidence should be provided, 
along with clear statement of rationale for the criteria.  
Item 9.  Strengths and weaknesses of each piece, or group of pieces, of evidence should 
be described. Descriptions should focus on its inherent risk of bias, and on the  method used by 
guideline developers to interpret the evidence.  
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Item 10. The collaborative method used to formulate recommendations should be 
described, along with outcomes, areas of disagreement, and the level of consensus.   
Item 12. Recommendations should be explicitly linked to their supporting evidence. 
When evidence is sparse and a recommendation is based on expert consensus, the nature of the 
link should be explicitly stated.   
Item 14. A timetable and methodology for guideline update should be provided. 
Domain 4: Clarity of Presentation 
The next domain, Clarity of Presentation, evaluates document usability. While 
background information and evidence analysis are crucial to guideline quality, for CPGs to be 
useful to busy clinicians these documents must provide answers to their questions, and those 
answers must be clear, unambiguous, and easy to find. Recommendations should be clear and 
specific, and all options should be enumerated. When the guideline is lengthy or complex, the 
most important recommendations should be grouped for easy access. To satisfy the criteria of 
Domain 4: 
Item 15. Recommendations should clearly specify and describe the option which was 
determined from the evidence to be most appropriate for an identified population with particular 
indications. Any uncertainty about recommendations should be disclosed in the guideline.    
Item 16.  Management guidelines should present all possible options and provide 
guidance as to which option is most appropriate for each condition variation.  
Item 17.  Key recommendations should answer the central clinical questions. These 
answers should be easy to find in the document.   
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Domain 5: Applicability 
The 5th domain of Applicability measures guideline features that promote its use and 
usefulness. Guideline criteria may help clinicians assess and improve the quality of their care 
practices, and they may be useful as measures of guideline effectiveness. 
Item 19.  To improve guideline effectiveness, advice and/or tools to enhance 
dissemination and implementation should be provided 
Item 21. To make guidelines part of an iterative health improvement process they should 
include criteria and tools for measuring their use and impact. Effective criteria should proceed 
directly from the key recommendations.  
Domain 6: Editorial Independence 
At issue in the final domain, Editorial Independence, is the concern for commercial 
influences that may bias guideline developers.  Interaction between clinicians and medical 
industries is essential to advancing medical technology and pharmacology, but close commercial 
relationships may color clinicians’ preferences when considering options.    To comply with 
AGREE’s Editorial Independence criteria: 
Item 23.  Members of a development group must declare any personal connection that 
could bias their interpretation of the evidence. Any such declarations should be explicitly stated.   
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Rubric Development 
Rubric Version 1 (RV1) 
As a first step in developing my rubric, I adopted 15 attributes from AGREE (Figure 1). 
Items selected for inclusion in this first version of my rubric focused on document composition; 
items focused entirely on methodology were omitted.  For each guideline evaluated, the included 
attributes will be rated for writing effectiveness on a 4-point scale, from “Strongly Disagree (1)” 




RUBRIC VERSION 1 
 
ATTRIBUTE 1 2 3 4 COMMENTS 
 
Domain 1. Scope and Purpose 
1.  Guideline objectives      
2.  Clinical question(s)      
3.  Target population      
4.  AGREE item omitted      
 
Domain 2. Stakeholder Involvement 
5.  AGREE item omitted      
6. Target users      
 
Domain 3  Rigor of Development 
7.  AGREE item omitted      
8.  Evidence selection criteria      
9.  Evidence strengths, limitations      
10. Method for formulating 
recommendations 
     
11.  AGREE item omitted      
12.  Link between evidence & 
recommendations 
     
13.  AGREE item omitted      
14. Updating procedure      
 
Domain 4. Clarity of Presentation 
15. Recommendations      
16. Management options      
17. Key recommendations      
 
Domain 5. Applicability   
18.  AGREE item omitted      
19. Implementation tools      
20.  AGREE item omitted      
21. Monitoring &/or audit criteria      
 
Domain 6. Editorial Independence 
22.  AGREE item omitted      
23. Competing interests of CPG 
development group 
     
Figure 1: Rubric Version 1 (RV1) 
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Guideline categories: Qualifying the rubric 
NGC currently publishes on its website summaries of more than 2500 CPGs. At their 
cores, CPGs all serve one overarching purpose: to make valid recommendations that will assist 
practitioners with health care decision-making. But CPGs address a broad spectrum of services 
whose basic purposes and complexities differ, and I propose that these differences need to be 
considered in the construction of guideline assessment tools.   
     Based upon the primary tasks addressed by each guideline, the NGC defines eleven 
guideline categories. NGC Guideline Categories include: 
Assessment of Therapeutic Effectiveness. This guideline’s function is to measure the 
benefit of the practice in question, considering the effectiveness of the practice and its 
acceptability to the patient. 
Counseling. This guideline’s function is to recommend methods professionals may use to 
educate or guide patients to better physical or emotional health. 
Diagnosis.  The function of this guideline is to recommend ways to identify and 
differentiate clinical conditions. Guidelines in this category may describe a multi-step process to 
include one or more branching decision junctures. 
Evaluation. An evaluation guideline outlines a process for gathering information from 
which a diagnosis and a possible treatment plan may be developed, or later in treatment to assess 
its effectiveness. 
Management.  Management guidelines describe a comprehensive process of integrating 
and implementing treatment and evaluation. 
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Prevention.  These guidelines recommend means to promote health and prevent physical 
and mental disorders  
Rehabilitation. These guidelines recommend interventions and techniques for restoring 
well-being. 
Risk Assessment. These guidelines recommend ways to assess the potential of harm 
resulting from a negative health factor or the lack of a beneficial factor. 
Screening. Guidelines in this category recommend means of early detection of disease or 
the increased likelihood of disease. 
Technology Assessment . These guidelines evaluate the use of a particular technology for 
a clinical purpose, comparing it to other technologies used for the same application.  
Treatment.  These guidelines recommend interventions meant to relieve illness or injury. 
Although the NGC describes these eleven separate “Guideline Categories,” in fact, most 
guidelines are comprised of elements of more than one category, with most incorporating 
“Treatment” (2481), “Management” (2240), and/or “Evaluation” (2168), along with elements of 
other categories. 
Guideline Category Assessment 
I propose that functional differences among these various categories create differences in 
the types of tasks they address, and that these differences are important variables to consider 
when judging guideline quality.  
To simplify guideline characterization by function, I suggest combining the eleven 
guideline categories differentiated by the NGC into three larger groups according to general task 
structures. 
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Category Group 1: Stratified Recommendations 
Of the eleven categories, five comprise guidelines that describe and compare options, 
stratifying the options by appropriateness: 
 Assessment of therapeutic effectiveness 
 Diagnosis 
 Risk assessment 
 Technology assessment 
 Treatment  
Guidelines in Category Group 1 (CG1) present evidence of relative effectiveness, 
benefits, and risks of each available option. Based upon strength of evidence, guidelines in this 
category stratify options and make corresponding practice recommendations. CG1 guidelines 
essentially make decisions for clinicians, and so should provide compelling evidence that the 
recommendations they advance are sound. Guidelines in this category may include evidence 
tables and may define rubrics used to grade evidence and recommendations. 
Category Group 2: Multi-option Recommendations 
The guidelines in these next 4 categories offer multiple options, not strictly stratified and 






Guidelines in Category Group 2 (CG2) list options that can be used together, or in some 
combination based on resources and patients’ preferences, to improve or promote well-being. 
Compared to CG1 guidelines, these guidelines leave more decision-making to the clinician. To 
support informed clinical decisions, CG2 guidelines should provide evidence of some measure of 
effectiveness, if not clear superiority, of each listed option for identified clinical variants.   
Category Group 3: Performance Recommendations 
Guidelines in the last two categories recommend a process for technical performance of a 
single, or of a bundled, intervention.  
 Evaluation 
 Management 
Guidelines in Category Group 3 (CG3) serve as performance manuals. These guidelines 
instruct clinicians on how to perform a particular task, or tasks. While there is an important role 
for evidence in these guidelines, particularly with respect to exam appropriateness and the 
composite of steps required to complete these tasks, the guideline body – the technical 
instruction – does not lend itself to “stratified evidence.” Category 3 Guidelines must be based 
on the experience and opinions of individuals who are experts at these tasks.   
In summary, these criteria that relate to guideline categories will be addressed in my 
rubric: 
CG1 Stratified Recommendation guidelines promote one option over others. 
Stratification should be based on high quality evidence demonstrating clear advantage(s) of the 
recommended option. The evidence should be presented in clear, unambiguous, unbiased 
language, with devices that simplify data interpretation.  
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CG1 guidelines appropriate decision-making, and so should prove superiority of 
recommended options.  
CG2 Multi-Option Recommendation guidelines provide multiple, largely non-stratified, 
options. Guidelines in this category should facilitate clinicians’ decision-making by providing 
thorough, broadly comprehensive information about each option and its possible application.  
CG2 guidelines inform decision-making and so should demonstrate effectiveness and 
application of recommended options. 
CG3 Performance guidelines lead clinicians through processes. These guidelines should 
conform to the standards of high-quality user manuals. 
CG3 guidelines recommend performance methods, and so should establish through 
references that they are informed by expert opinion, and they should meet the standards of 
performance manuals.  
Adjusting the Rubric for Category Differences 
Next I re-evaluated my rubric, considering the characteristics of each Category Group. 
Weighing the fundamental information and burden of evidence necessary for each, I determined 
which RV1 attributes related to those guideline requirements.  The following table (Table 1) 
presents my assessment of the relevance of attributes to guideline categories and, in turn, to the 
measure of their quality. 
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Table 1: Category Relevance 
  Category Relevance   Domain.Item Attribute 
CG1 CG2 CG3 
1.1 Guideline objectives √ √ √ 
1.2 Clinical question(s) √ √ √ 
1.3 Target population √ √ √ 
2.6 Target users √ √ √ 
3.8 Evidence selection criteria √ √ √ 
3.9 Evidence strengths, limitations √ √  
3.10 Method for formulating recommendations √ √  
3.12 Link between evidence & recommendations √ √  
3.14 Updating procedure √ √ √ 
4.15 Recommendations √ √ √ 
4.16 Management options √ √ √ 
4.17 Key recommendations √ √ √ 
5.19 Implementation tools √ √ √ 
5.21 Monitoring &/or audit criteria √ √ √ 
6.23 Competing interests of CPG development 
group 
√ √ √ 
 
According to this assessment, 11 of the RV1 items are relevant to all guideline categories. 
The remaining items, numbers 3.8, 3.9, 3.10, and 3.12, are necessary for CG1 guidelines to 
establish superiority of the recommended options, and to CG2 guidelines to demonstrate the 
effectiveness of recommended options. I propose that those items are not, however, relevant to 
CG3 guidelines whose function is not to promote options, but, rather, to recommend 
performance methods.  
While CG3 guidelines do not need to meet all of the criteria set forth by AGREE, I 
propose that, related to their function as performance manuals, guidelines in this category need to 
meet some requirements not included in AGREE. According to Gerson (362), user manuals 
should present clearly defined, well-developed steps and exhibit effective document design. 
These two attributes, essentially an extension of AGREE Domain 4, should be considered when 
assessing CG3 Guideline quality, so I will add them to my Rubric Version 1. Guidelines in CG3 
 47
also need to establish ethos by referencing expert opinion to support recommended procedures, 
so I will add an item for that attribute as well. 
In addition to the three just-described attributes, I propose that one more is essential to 
the quality of guideline documents in the CG3 group: justification for performance. Particularly 
for emerging ultrasound applications where evidence of procedure benefit is sparse, establishing 
appropriateness will be of critical importance to prevent their misuse and overuse.   
Finally, after review of several guidelines, I conclude that guideline documents vary in 
the quality of their organization, which affects their usability. Including the 4 additional quality 
attributes to be measured in CG3 guidelines, and adding logical presentation as an assessment 
item for all groups, I propose this revised list of quality attributes. (See Table 2.) Check marks 
indicate relevant attributes for guidelines in each category.  
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Table 2: Category-Adjusted Guideline Quality Assessment 
  Guideline Category   Item 
# 
Attribute 
CG1 CG2 CG3 
1. Guideline objectives √ √ √ 
2. Health question(s) √ √ √ 
3. Target population √ √ √ 
4. Target users √ √ √ 
5. Evidence selection criteria √ √  
6. Evidence strengths, limitations √ √  
7. Method for formulating recommendations √ √  
8. Link between evidence & recommendations √ √  
9. Updating procedure √ √ √ 
10. Recommendations √ √ √ 
11. Management options √ √ √ 
12. Key recommendations √ √ √ 
13. Implementation tools √ √ √ 
14. Monitoring, audit criteria, and future research √ √ √ 
15. Competing interests of CPG development group √ √ √ 
16. Logical presentation √ √ √ 
17. Clearly defined steps   √ 
18. Effective document design   √ 
19. Expert reference   √ 
20. Appropriateness criteria   √ 
 
From the assessment rubric just described, I created the following worksheet (See Figure 





Guideline Category(s):    GC1  ___________   GC2   ____________   GC3___________ 
Instructions: 
Rate Items 1 – 12 for ALL Guidelines. 
4 = Strongly Effective          
3 = Moderately Effective 
2 = Moderately Ineffective 
1 = Strongly Ineffective, or Missing 
GC1 and GC2 Guidelines:  Rate Items 13 – 16 * 
GC3 Guidelines : Rate Items 17 – 20 ** 
 
# ATTRIBUTE RATING COMMENTS 
 1 2 3 4  
1 Guideline objectives      
2 Health question(s)      
3 Target population      
4 Target users      
5 Updating procedure      
6 Recommendations      
7 Management options      
8 Key recommendations      
9 Implementation tools      
10 Monitoring, audit criteria, and future research      
11 Competing interests of CPG development group      
12 Logical presentation      
 
*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY! 
13 Evidence selection criteria      
14 Evidence strengths, limitations      
15 Method for formulating recommendations      
16 Link between evidence & recommendations      
 
**Rate Items 17 – 20 for CG3 guidelines ONLY! 
17 Appropriateness criteria      
18 Clearly defined steps      
19 Effective document design      
20 Expert reference      
 
TOTAL SCORES: 
     
  = ______________ 
Figure 2: Category-Adjusted Guideline Assessment Tool 
 
In Chapter Four, I present my analyses of six clinical practice guidelines that address 
various ultrasound applications. Using the rubric above, I assess text components of these 
documents and rate how effectively each one promotes guideline validity and usability. 
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CHAPTER FOUR: ANALYSIS 
In this chapter I present my analyses of six clinical practice guidelines that address 
various ultrasound applications. Using the rubric I described in Chapter Three, I assess text 
components of these documents and rate how effectively the writing supports each attribute and 
promotes guideline validity and usability.  Although I assign a score to attributes and to each 
document overall, the primary purpose of my assessments is to identify writing practices that 
weaken guidelines and to highlight practices that make the documents strong.  With this study I 
evaluate features and writing challenges fundamental to CPGs, but I direct special focus toward 
those attributes that may prove most important, and most challenging, for developers of 
guidelines for emerging ultrasound applications. I believe findings and conclusions from these 
analyses may be used by guideline drafters to enhance the quality of CPGs for emerging users.  
Guideline Assessments 
The six CPGs I selected all address topics related to ultrasound, but they span a broad 
spectrum of settings, target user groups, and types of applications. Where two guidelines are 
published by the same organization, I review them together, describing common features and 
noting differences.   
Guideline 1: American College of Emergency Physicians  
Critical issues in the initial evaluation and management of patients presenting to the emergency 
department in early pregnancy (2003)  
The first two guidelines I review are published by the American College of Emergency 
Physicians (ACEP). The first of these, the earliest published among this group, is ACEP’s 
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Clinical Policy: Critical Issues in the Initial Evaluation and Management of Patients Presenting 
to the Emergency Department in Early Pregnancy. This ten-page guideline written in 2003 
describes point-of-care ultrasound as one component of a diagnostic plan. The guideline is 
composed of seven sections.  In the first section, the “Introduction,” the guideline’s rationale and 
critical issues are provided. Section 2, “Methodology,” describes the literature review method 
and criteria for ranking evidence and for grading recommendations. Section 3, “Critical 
Questions,” presents diagnostic questions related to interpretation of blood pregnancy test results. 
For each question, recommendations follow a review of relevant evidence. Two of these three 
questions relate blood test results to findings from point-of-care ultrasound examination. The 4th 
and 5th sections, “Methotrexate in Ectopic Pregnancy” and “Rh Seroconversion and Indications 
for Anti-D Immunoglobulin,” appropriateness of these treatments is questioned. Following a 
review of the evidence for each, patient management recommendations are provided.  No 
questions are identified for sections 6, “Threatened or Complete Abortion or Ectopic 
Pregnancy,” or 7, “Minor Abdominal Trauma,” but evidence related to the conditions is 
discussed, with recommendations following. After the body of the guideline, members of the 
document development group are listed. References listed at the end of the guideline are also 
embedded in the text to indicate support for evidence statements.  
Using the Category-Adjusted Guideline Quality Assessment Worksheet I prepared in 
Chapter 3, I rated attributes of this guideline. The findings are presented below in Table 3. 
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Table 3: Clinical Policy: Critical Issues in the Initial Evaluation and Management of Patients 
Presenting to the Emergency Department in Early Pregnancy (2003) 
 
Guideline Developer: American College of Emergency Physicians 
    
Guideline Category(s):         GC1 ___x___     GC2  ______   GC3 ______     
 
Instructions: 
Rate Items 1 – 12 for ALL Guidelines. 
4 = Strongly Effective          
3 = Moderately Effective 
2 = Moderately Ineffective 
1 = Strongly Ineffective, or Missing 
GC1 and GC2 Guidelines:  Rate Items 13 – 16 * 
GC3 Guidelines : Rate Items 17 – 20 ** 
 
# ATTRIBUTE RATING COMMENTS 
 4 3 2 1  
1 Guideline objectives x    Clear statement of clinical imperative 
and topics. 
(see comments below) 
2 Health question(s) x    “Critical Questions” are explicit, 
bolded, prominently located, and 
numbered for easy identification. 
(see comments below) 
3 Target population x    The title specifies the target population. 
4 Target users x    The target user group is defined 
(see comments below) 
5 Updating procedure x    A plan for guideline review and 
updating was provided. 
(see comments below) 
6 Recommendations x    Recommendations use unambiguous, 
directive language and directly state 
justification for each recommendation. 
Strength grades are included with each 
recommendation. 
(see comments below) 
7 Management options x    For a particular setting, 2 options were 
discussed, and option selection 
guidance was provided. 
(see comments below) 
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# ATTRIBUTE RATING COMMENTS 
8 Key recommendations x    Key recommendations appear as 
responses to specific health questions. 
Recommendations are easily found 
under informative, bolded headings. 
9 Implementation tools   x  The recommendations are easy to 
access, but the guideline could be 
enhanced with additional 
implementation tools. 
10 Monitoring, audit criteria, 
and future research 
   x None of the recommendations meet the 
developers’ criteria for Level A 
strength, so the value of the guideline 
might be enhanced by specific 
suggestions for further research. 
11 Competing interests of 
CPG development group 
   x No conflict of interest disclosures 
appear in the guideline. 
12 Logical presentation 
 
x    Easy to follow progression from 
clinical question through evidence to 
recommendations. 
 
*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY! 
13 Evidence selection criteria x    Details of search and selection process 
are provided. 
(see comments below) 
14 Evidence strengths, 
limitations  
x    The method of interpreting evidence 
and guarding against biased 
recommendations was described. 
(see comments below) 
15 Method for formulating 
recommendations 
x    The method is explicitly described. 
(see comments below) 
16 Link between evidence & 
recommendations 
x    Each clinical question is explicitly 
answered with review of relevant 
literature, and recommendations are 
provided as conclusions from the 
evidence. 
(see comments below) 
 
**Rate Items 17 – 20 for CG3 guidelines ONLY! 
17 Appropriateness criteria      
18 Clearly defined steps      
19 Effective document design      















1. Guideline objectives. 
“In the past decade, despite major changes in epidemiology, incidence, and demographic, 
ectopic pregnancy remains the most common cause of maternal death and serious morbidity in 
the first trimester of pregnancy. For this reason, critical issues selected for this policy revision 
are those primarily associated with initial evaluation and management of ectopic pregnancy… 
Those critical issues include: (1) … , (2)… , and (3) … .” 
“This policy revision presents evidence for answering important questions about these 
critical diagnostic and management issues.” 
2. Clinical questions. 
“Is transvaginal ultrasound useful in detecting intrauterine pregnancy when the serum 
hCG level is less that 1,000 mIU/mL?” 
“Is transvaginal ultrasound useful in detecting ectopic pregnancy when the serum hCG 
level is less than 1,000 mIU/mL?” 
“What is the role…?”  etc. 
4. Target users. 
“This guideline is intended for physicians working in hospital-based emergency 
departments.” 
5. Updating procedure. 
“Clinical policies are scheduled for revision every 3 years; however, interim reviews are 





“Level B recommendations. Obtain a repeat serum hcG determination at least 2 days after 
the initial presentation because it is useful in characterizing the risk of ectopic pregnancy and the 
probability of a viable intrauterine pregnancy.” 
7. Management options. 
“Because the symptoms associated with gastrointestinal side effects of methotrexate 
therapy may mimic an acute ectopic rupture, rule out ectopic rupture resulting from treatment 
failure before attributing gastrointestinal symptoms to methotrexate toxicity. “ 
13. Evidence selection criteria. 
“Abstracts and articles were reviewed by subcommittee members, and pertinent articles 
were selected. These were evaluated, and articles addressing the questions considered in this 
document were chosen …” 
14. Evidence strengths/limitations. 
“All publications were graded by at least 2 of the subcommittee members…” 
“Factors such as heterogeneity of results, uncertainty about effect magnitude and 
consequences, strength of prior beliefs, and publication bias…might lead to a downgrading of 
recommendations.” 
15. Method for formulating recommendations.   
“During the review process, all articles were given a baseline ‘strength of evidence’ by 
the subcommittee members according to [explicitly stated] criteria.” “Recommendations 




16.  Link between evidence and recommendations. 
The clinical question: “Is transvaginal ultrasound useful in detecting intrauterine 
pregnancy when the serum hCG level is less than 1,000 mIU/mL?” 
The evidence: From cited study #1: “All 9 pregnancies were correctly identified …from 
300 mIU/mL and 1,000 mIU/mL”  From study #2: “… correctly diagnosed … 800 mIU/mL.”  
From additional studies similar evidence was reported.   
The recommendation: “Consider transvaginal ultrasound because it may detect 
intrauterine pregnancy when the serum hCG level is below 1,000 mIU/mL.” 
Guideline 2. American College of Emergency Physicians 
Clinical Policy: Critical Issues in the Evaluation and Management of Emergency Department 
Patients With Suspected Appendicitis (2010)  
The second ACEP guideline, Clinical Policy: Critical Issues in the Evaluation and 
Management of Emergency Department (ED) Patients With Suspected Appendicitis was 
published 7 years later in 2010. In this much lengthier 35-page document the authors describe a 
management plan for patients who visit the ED with complaints of acute abdominal pain. In the 
“Introduction” and “Methodology” sections of this guideline, the  information provided is similar 
in type to the information provided in corresponding sections of the early pregnancy guideline. 
There are, however, some important differences between the two guidelines. ACEP's 
2002 guideline on managing pregnant patients in the ER lists the names of development group 
members at the end of the guideline; this 2010 guideline from ACEP lists the development group 
on the cover, with their titles expanded to include their titles and institutional affiliations. Among 
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the 2002 developers, no one is described as a methodologist; from the 2010 group, two 
methodologists are identified.  
The format for reporting recommendations has evolved as well. In the 2002 guideline 
each explicit health question is followed by a review of the literature that addresses the question. 
Resulting recommendations follow the literature review. The format of the 2010 guideline 
enhances usability by providing the recommendations immediately after the questions they 
answer, with the literature review following the recommendations. While the format used by 
guideline developers in 2002 was logical, the newer format is more user-friendly. In addition to 
the narrative lit reviews in the body of the guideline, the 2010 guideline provides study analyses 
in evidentiary tables. A comparison of these two guidelines reveals maturation of the guideline 
development process with attention to easier user access and greater transparency.  
In Table 4, below, I present attribute ratings for the second guideline.  
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Table 4: Clinical Policy: Critical Issues in the Evaluation and Management of Emergency 
Department Patients With Suspected Appendicitis (2010) 
 
Guideline Developer: American College of Emergency Physicians 
 
Guideline Category(s):  GC1 ___x___     GC2  __X____   GC3 ______     
 
Instructions: 
Rate Items 1 – 12 for ALL Guidelines. 
4 = Strongly Effective          
3 = Moderately Effective 
2 = Moderately Ineffective 
1 = Strongly Ineffective, or Missing 
GC1 and GC2 Guidelines:  Rate Items 13 – 16 * 
GC3 Guidelines : Rate Items 17 – 20 ** 
 
# ATTRIBUTE RATING COMMENTS 
  4 3 2 1  
1 Guideline objectives x    The diagnostic challenge, and clinical 
and legal impacts of the clinical 
problem are discussed; Guideline goals 
are stated. 
(see comments below) 
2 Health question(s) x    Questions define patient groups and 
imaging options considered, and they 
provide framework for comparisons. 
Questions are prominently located, 
bolded, and numbered for easy 
identification. 
(see comments below) 
3 Target population x    Along with the overall target 
population, subgroups of interest are 
identified, as well as excluded groups. 
(see comments below) 
4 Target users x    The intended user group is defined, 
and all groups who contributed to 
development of the CPG were listed.  
Intended use of the guideline is 
described. 
(see comments below) 
5 Updating procedure x    A plan for guideline review and 
updating was provided. 
(see comments below)  
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# ATTRIBUTE RATING COMMENTS 
6 Recommendations x    Recommendations are graded for 
strength; justification is provided in the 
literature review immediately 
following. Recommendations are 
written using unambiguous, directive 
language. 
(see comments below) 
7 Management options x    For a particular setting, 2 options were 
discussed and option selection 
guidance was provided. 
(see comments below) 
8 Key recommendations x    Key recommendations immediately 
follow questions to which they 
respond. Recommendations are easily 
found under informative, bolded 
headings. 
9 Implementation tools   x  The recommendations are easy to 
access, but the guideline could be 
enhanced with additional 
implementation tools. 
10 Monitoring, audit criteria, 
and future research 
x    Future areas of research are suggested 
to improve answers to the guideline’s 
questions. 
(see comments below) 
11 Competing interests of 
CPG development group 
x    The guideline contains a bolded 
conflict of interest disclosure. 
(see comments below) 
12 Logical presentation x    Direct, uncluttered connection between 
questions and recommendations.  
 
*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY! 
13 Evidence selection criteria x    The Methodology section details the 
literature search and selection 
parameters. 
14 Evidence strengths, 
limitations 
x    Evidence is reviewed both as a 
narrative to answer each question, and 
in evidentiary tables. 
(see comments below) 
15 Method for formulating 
recommendations 
x    The method is explicitly described. 
(see comments below) 
16 Link between evidence & 
recommendations 
x    Guideline drafters’ interpretive link 
between evidence and 
recommendations is reported. 
(see comments below) 
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# ATTRIBUTE RATING COMMENTS 
 
**Rate Items 17 – 20 for CG3 guidelines ONLY! 
17 Appropriateness criteria      
18 Clearly defined steps      
19 Effective physical design      
20 Source of expertise 
identified 
     
 
TOTAL SCORES: 
60  2   




1.  Guideline objectives. 
“Abdominal pain is a high-volume, high-risk chief complaint… The diagnosis of 
appendicitis can be challenging even in the most experienced of clinical hands.” 
“A writing subcommittee reviewed the literature to derive evidence-based 
recommendations to help clinicians answer [these] critical questions [related to management of 
emergency department patients with abdominal pain]:  (1)…, (2) …, (3) … .” 
2. Health questions. 
“Can clinical findings … guide decision-making…? 
“… what is the role of contrast?” 
“… what are the roles of CT and ultrasound in diagnosing acute appendicitis?” 
3. Target population. 
“This guideline is intended for patients presenting to the ED with acute, nontraumatic 
abdominal pain and possible or suspected appendicitis.” 
“In adult patients with suspected acute appendicitis…” 
“In children with suspected acute appendicitis…” 
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“… not intended to address the care of patients with trauma-related abdominal pain, or 
pregnant patients.” 
4.  Target users. 
“This guideline is intended or physicians working in hospital-based EDs.” 
“This policy is not intended to be a complete manual on the evaluation and management 
of patients with nontraumatic acute abdominal pain but rather a focused examination of critical 
issues that have particular relevance to the current practice of emergency medicine…this 
guideline defines for the physician those strategies for which medical literature exists to provide 
support for answers to the crucial questions addressed in this policy.” 
5. Updating procedure. 
“Clinical policies are scheduled for revision every 3 years; however, interim reviews are 
conducted when technology or the practice environment changes significantly.” 
6. Recommendations. 
“In children, use ultrasound to confirm acute appendicitis but not to definitively exclude 
acute appendicitis. 
7. Management options. 
“Given the concern over exposing children to ionizing radiation, consider using 
ultrasound as the initial imaging modality. In cases in which the diagnosis remains uncertain 
after ultrasound, CT may be performed.” 
10. Monitoring &/or audit criteria/Research. 
Guideline question 2”In adult patients with suspected acute appendicitis who are 
undergoing a CT scan, what is the role of contrast?”  
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Research suggestion 1: “A prospective comparison of CT with no contrast, IV contrast 
alone, and oral and IV contrast (for appendicitis), using the newest CTG technology. This study 
could be done in both adult and pediatric populations.” 
11. Competing interests of CPG development group. 
“There were no relevant industry relationships disclosed by the subcommittee 
members…” 
14. Evidence strengths, limitations. 
In evidentiary tables each study is analyzed by year, design, intervention, outcome 
measure, results, limitations, and class.  
15. Method for formulating recommendations. 
“All articles used in the formulation of this clinical policy were graded by at least 2 
subcommittee members for strength of evidence and classified by the subcommittee members in 
to 3 classes of evidence on the basis of…” 
“Articles were then grade on 6 dimensions thought to be most relevant to the 
development of a clinical guideline: …” 
“Articles received a final grade …” 
“Clinical findings and strength of recommendations regarding patient management were 
then made according to the following criteria: 
Level A recommendations… 
Level B… 




16. Link between evidence & recommendations. 
“Theoretically, higher Alvarado scores are associated with a higher likelihood of 
appendicitis and lower scores with a lower likelihood of appendicitis. Whether the Alvarado 
score can reliably predict the need for CT is debatable. [cited studies discussed] The authors 
concluded that patients with scores of 3 or less should not have CT, those with scores between 4 
and 6 should have CT, and those with scores 7 or higher…  The authors recommended imaging 
even patients with low Alvarado scores.” 
Guideline 3: American Urological Association 
Consensus Statement on Urologic Ultrasound Utilization (2007)  (Analysis: Table 5) 
The third guideline was first published by the American Urological Association (AUA) in 
1993 and periodically revised, most recently in 2007. The guideline is presented in five sections: 
Section 1, the “AUA Policy Statement on Imaging Services,” affirms urologists as qualified to 
perform ultrasound as part of their patient care. “Section 2, “Equipment, Documentation, 
Indications,” is the operational part of the guideline. This section begins with general 
recommendations for equipment and for documentation standards, and then follows with targeted 
details, technique instructions, and indications for six ultrasound exams performed by these users. 
This largest section is followed by a discussion of “Educational Requirements” set forth by this 
organization for their members who perform ultrasound, and it details the curriculum of the 
ultrasound component of Urology Residency Education. Next, Section Five, “Patient Safety,” 
provides a statement about responsible use of ultrasound. 
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This guideline is generally easy to follow with bulleted lists and good use of white space. 
Its explanations of technique, however, are embedded in text, rather than presented in a more 
user-friendly list format. Table 5 reports attribute ratings. 
Table 5: Consensus Statement on Urologic Ultrasound Utilization (2007) 
 
Guideline Developer: American Urological Association (2007) 
 
Guideline Category(s) :  GC1 _____     GC2  ______   GC3 ____X__     
 
Instructions: 
Rate Items 1 – 12 for ALL Guidelines. 
4 = Strongly Effective          
3 = Moderately Effective 
2 = Moderately Ineffective 
1 = Strongly Ineffective, or Missing 
GC1 and GC2 Guidelines:  Rate Items 13 – 16 * 
GC3 Guidelines : Rate Items 17 – 20 ** 
 
# ATTRIBUTE RATING COMMENTS 
 4 3 2 1  
1 Guideline objectives   x  Objectives are not clearly defined. 
2 Health question(s)   x  No clinical questions are provided to 
link exam indications to recommended 
practices 
3 Target population   x  The population is characterized per 
indications, but no other patient 
descriptions are provided. 
4 Target users x    Urologists are identified as target users; 
suitability of these users is strongly 
affirmed.  
(see comments below) 
5 Updating procedure    x No plan is provided. 
6 Recommendations  x    Equipment, performance, and 
documentation recommendations are 
provided, and their relative strengths 
are characterized. (see comments 
below) 
7 Management options x    When more than one approach may be 
used, all are clearly stated.  
(see comments below) 
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# ATTRIBUTE RATING COMMENTS 
8 Key recommendations    x Recommendations are described, but 
none are easily identified as key 
answers to clinical questions. 
9 Implementation tools    x No guideline implementation tools are 
provided or suggested. 
10 Monitoring, audit criteria, 
and future research 
   x No assessment criteria are provided.  
(see comments below) 
11 Competing interests of 
CPG development group 
   x Conflict of interest statements are not 
provided. 
12 Logical presentation x    Global statements begin and end the 
guideline, with individual exams 
grouped under descriptive headings.  
 
*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY! 
13 Evidence selection criteria      
14 Evidence strengths, 
limitations 
     
15 Method for formulating 
recommendations 
     
16 Link between evidence & 
recommendations 
     
 
**Rate Items 17 – 20 for CG3 guidelines ONLY! 
17 Appropriateness criteria  x   Provides opinion that patient care is 
optimized when urologists perform 
their patients’ ultrasound exams, but 
does not offer supporting literature.  
(see comments below) 
18 Clearly defined, ordered 
steps 
 x   Steps are clearly stated and concise, but 
they are grouped in paragraphs, making 
the beginning of each step difficult to 
locate. 
19 Effective document design   x  Instructions are compressed into dense 
paragraphs. The user would follow the 
instructions more easily if steps were 
separated and numbered. No graphics 
are included. 
20 Expert reference x    AUA, an organization of urologists, is 
defined as the guideline developer. 
 


















4.  Target users. 
“The AUA affirms that urologists are the physicians best qualified to diagnose, manage 
and treat diseases and conditions of the genitourinary tract in patients of all ages.” 
“Urologists combine the technical skill in the use of imaging equipment with the 
cognitive skills of the underlying disease process…” 
“The acquisition and maintenance of skills and knowledge associated with imaging 
technology is assured by the Accreditation Council for Graduate Medical Education residency 
review committee for urology…”  
Note: Section 3, Educational Requirements, details the ultrasound training residents 
receive, listing didactic areas of instruction and describing hands-on training. Post-residency 
training is also described, and the extent of ultrasound knowledge tested for urology certification 
is characterized. This method of defining training guidelines may be of value as a model for 
other emerging user groups. 
6.  Recommendations 
“The equipment should display mechanical and thermal indices and provide for adjusting 
power output.”   
“An antibiotic may be administered if biopsy is anticipated.”  
“A moderately filled bladder is necessary for optimal imaging of the bladder.” 
7. Management options 
“The needle guide may be a single-use device or a reusable device.”  
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“The bladder should be scanned in the transverse and sagittal views. Bladder imaging can 
also be performed using [approach 1] or [approach 2]. It may also be performed by [approach 3] 
using special ultrasound transducers…” 
10.  Monitoring &/or audit criteria 
Note: Patient satisfaction and outcomes studies could be recommended to evaluate 
appropriateness of urologists performing ultrasound exams 
17. Appropriateness criteria  
“Urologists integrate an understanding of the risks and benefits of imaging technologies 
with the clinical care of the patient. Patient care is optimized when urologists coordinate the use 
of appropriate imaging techniques and equipment in the setting most beneficial to their patients.” 
Guideline 4: American College of Cardiology Foundation, et al 
2008 Appropriateness Criteria for Stress Echocardiography: A Report of the American College 
of Cardiology Foundation Appropriateness Criteria Task Force, American Society of 
Echocardiography, American College of Emergency Physicians, American Heart Association, 
American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and 
Interventions, Society of Cardiovascular Computed Tomography, and Society for 
Cardiovascular Magnetic Resonance Endorsed by the Heart Rhythm Society and the Society of 
Critical Care Medicine.  (Analysis: Table 6) 
The fourth guideline explores appropriateness concerns for this traditional ultrasound 
application.  The text of this 22-page strongly collaborative document is preceded by a list of 
guideline developers and their affiliations. 
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This guideline addresses the dual tasks of promoting optimal patient outcomes and 
maintaining cost-effectiveness. Following an Abstract, the document contains eight major 
sections, including ten tables. In the first section, the “Preface,” the guideline objective is stated, 
along with a description of the collaborative appropriateness-rating process employed by the 
committee. The second section, the “Introduction,” explains the guideline’s rationale, and in the 
next section, “Methods,” the drafters describe the formal consensus method used to reduce bias 
in this largely expert opinion-based guideline. The fourth section defines abbreviations. The fifth 
section provides a general discussion of Results of Ratings, followed in sections six and seven 
with reports of scores of Stress Echocardiography Appropriateness Criteria by Indication and by 
Appropriateness Category, respectively. Section Eight provides a General Discussion of the 
usefulness and limitations of appropriateness criteria, and of potentially valuable research 
projects. Finally, the guideline concludes with references and four appendices. Appendices 
include an assessment algorithm and financial disclosures, and expand on definitions, guideline 
development methods, and compositions of working groups.  
Stress echocardiographic examinations, the subject of this guideline, have been 
performed by “traditional” users for more than a decade, but the major challenge inherent in 
development of this CPG underlies guideline development for emerging applications: scarce data, 
compelling a need to rely largely on expert opinion to generate recommendations. Methods used 
by these guideline drafters to reduce bias and promote validity may be useful to drafters of 
guidelines for emerging ultrasound applications.  
Exam appropriateness is also likely to be a crucial issue for emerging ultrasound 
applications, and the introduction to this guideline effectively summarizes the issue. According 
to these authors, technological improvements have increased ultrasound’s diagnostic utility, but 
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along with that benefit have come increased possibilities of misuse and overuse of the modality. 
The authors raise concerns that this ultrasound examination may be prescribed for patients who 
will not benefit from it, or who may benefit but could have been managed effectively without it. 
Beyond the immediate expense of an unnecessary exam, the authors point out the danger of 
exam results prompting “harmful and costly downstream testing” or unnecessary follow-up 
exams. Rating of this guideline’s attributes follow in Table 6. 
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Table 6: Appropriateness Criteria for Stress Echocardiography (2008) 
 
Guideline Developer: American College of Cardiology Foundation Appropriateness 
Criteria Task Force, American Society of Echocardiography, American College of 
Emergency Physicians, American Heart Association, American Society of Nuclear 
Cardiology, Society for Cardiovascular Angiography and Interventions, Society of 
Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic 
Resonance. 
 
Guideline Category:        GC1 ___x______     GC2  _________   GC3 _________     
 
Instructions: 
Rate Items 1 – 12 for ALL Guidelines. 
4 = Strongly Effective          
3 = Moderately Effective 
2 = Moderately Ineffective 
1 = Strongly Ineffective, or Missing 
GC1 and GC2 Guidelines:  Rate Items 13 – 16 * 
GC3 Guidelines : Rate Items 17 – 20 ** 
 
# ATTRIBUTE RATING COMMENTS 
 4 3 2 1  
1 Guideline objectives x    Objectives and expected outcomes 
from the guideline are described 
(See comments below) 
2 Health question(s) x    Questions concerning appropriateness 
of the procedure for identified 
indications are provided graphically in 
tabled lists. 
(See comments below) 
3 Target population x    The target population is broadly 
defined, and then differentiated into 
several smaller groups according to 
their symptoms and clinical conditions. 
(See comments  below) 
4 Target users x    Clinicians, facilities, and payers are 
identified as target users, and 
suggestions are provided as to how the 
document might be used. 
(See comments  below) 
5 Updating procedure   x  Necessity for updating was 
acknowledged, but no plan was 
provided. 
(See comments  below) 
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# ATTRIBUTE RATING COMMENTS 
6 Recommendations x    Recommendations take the form of 
quantitative appropriateness rating of 
the procedure for each clinical variant. 
(See comments below) 
7 Management options x    The document provides guidance on 
how to use appropriateness scores. 
8 Key recommendations x    Appropriateness ratings are easily 
found in the guideline’s tables. 
9 Implementation tools x    The tables are well-formatted and easy 
to reference. 
10 Monitoring, audit criteria, 
and future research 
x    Areas wherein future research is needed 
are described. 
(See comments below) 
11 Competing interests of 
CPG development group 
x    A strong, specific statement addresses 
potential relationships between CPG 
developers and industrial interests. 
Additionally, each author’s 
professional affiliation and role in the 
CPG development process is listed.   
(See comments below) 
12 Logical presentation x    A table of contents demonstrates a 
logical, easily accessible document 
structure. 
 
*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY! 
13 Evidence selection criteria x    “Relevant guidelines,” along with their 
reference lists, were identified as the 
sources of evidence. Key words are 
provided with the reference list. 
14 Evidence strengths, 
limitations 
  x  The considered evidence is 
qualitatively described as “relevant,” 
“objective,” and “nonbiased,” but no 
formal evidence-grading system is 
provided. 
(See comments below) 
15 Method for formulating 
recommendations 
x    This guideline draws strongly on 
judgment and expert opinion for its 
recommendations. The committee’s 
formal use of a modified Delphi 
exercise is reported, and other steps the 
committee took to reduce the risk of 
bias are described.  
(See comments below) 
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# ATTRIBUTE RATING COMMENTS 
16 Link between evidence & 
recommendations 
x    The role of expert consensus as the link 
is explicitly stated. 
(See comments below) 
 
**Rate Items 17 – 20 for CG3 guidelines ONLY! 
17 Appropriateness criteria      
18 Clearly defined steps      
19 Effective document design      
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1. Guideline objectives. 
 “In an effort to respond to the need for the rational use of imaging services in the 
delivery of high quality care, the American College of Cardiology Foundation (ACCF) has 
undertaken a process to determine the appropriateness of cardiovascular imaging for selected 
patient indications.” 
“The ultimate objective of appropriateness criteria is to improve patient care and health 
outcomes in a cost-effective manner but is not intended to ignore ambiguity and nuance intrinsic 
to clinical decision making.” 
“The primary objective of this report is to provide guidance regarding the perceived 
suitability of stress echocardiography for diverse clinical scenarios.” 
2. Health question(s). 
Comment: Fifty-one indications were evaluated and questioned as to appropriateness. 
The guideline developers succeeded in presenting this large number of questions concisely by 
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listing them in tables. The questions were made even more accessible by being grouped 
according to several variations in the clinical scenario. 
3. Target population. 
“All indications are assumed to apply to adult patients (18 years of age or older).” 
Comment: Table headings further differentiate the population. 
4. Target users. 
“Clinicians could use the ratings as a decision support or educational tool when ordering 
a test or providing a referral to another qualified physician. The criteria also may be used to 
facilitate discussion with referring clinicians who have patterns of ordering tests for 
inappropriate indications. Facilities and payers may choose to use the criteria either 
prospectively in the design of protocols, automated order entry, and pre-authorization procedures, 
or retrospectively for quality reports. It is hoped that payers will use this document as the basis to 
inform rational strategies to ensure that their members receive the highest-quality, cost –effective 
cardiovascular care.” 
“When used to assess performance, appropriateness criteria should be applied in 
conjunction with systems that support quality improvement.”  
5. Updating procedure. 
“It will be necessary to periodically assess and update the indications and criteria as 
technology evolves and new data and field experience become available.” 
6. Recommendations. 
“Score 7 to 9” – Appropriate 
“Score 4 to 6” – Uncertain 
“Score 1 to 3” – Inappropriate  
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7.  Management options. 
“If major risk predictors are present, Figure A1 suggests consideration of coronary 
angiography and postponing or canceling noncardiac surgery. Once perioperative risk predictors 
are assessed based on the algorithm, then the surgical risk and patient’s functional stats should be 
used to establish the need for noninvasive testing.”  
10. Monitoring, audit criteria, and future research. 
“Future research analyzing patient outcomes utilizing indications rated appropriate would 
help ensure the equitable and efficient allocation of resources for diagnostic studies. Review of 
medically necessary care may also improve the understanding of regional variations in imaging 
utilization. Further exploration of the indications rated as “uncertain” will help generate the data 
required to further define the appropriateness of stress echocardiography. Finally, it will be 
necessary to periodically assess and update the indications and criteria as technology evolves and 
new data and field experience become available.” 
11. Competing interests of CPG development group. 
“The ACCF and its partnering organizations rigorously avoid any actual, perceived, or 
potential conflicts of interest that may arise as a result of an outside relationship or personal 
interest of a member of the Technical Panel. Specifically, all panelists are asked to provide 
disclosure statements of all relationships that may be perceived as real or potential conflicts of 
interest….A table of disclosures of the Technical Panel and Task Force Members can be found in 
the Appendix D.” (Appendix D presents a table listing for each committee member any research 
grants, speaking support, stock ownership, board of director affiliations, and industrial 
consultation relationships.) 
 75
Example of author listing: “Pamela S. Douglas, MD, MACC, FAHA, FASE-Lead Author, 
Appropriateness Criteria for Stress Echocardiography-Past President, ACC, Past President, ASE, 
Ursula Geller Professor of Research in Cardiovascular Diseases, Duke University Medical 
Center, Durham, NC.” 
14. Evidence strengths, limitations. 
“Care was taken in providing objective, nonbiased information, including guidelines and 
key references, to the Technical Panel.” 
15. Method for formulating recommendations. 
“To prevent bias in the scoring process, the Technical Panel deliberately was not 
comprised solely of specialists in the particular procedure under evaluation. Specialists, while 
offering important clinical and technical insights, might have a natural tendency to rate the 
indications within their specialty as more appropriate than nonspecialists. In addition, care was 
taken in providing objective, nonbiased information, including guidelines and key references, to 
the Technical Panel.” 
“Two rounds of ratings with lively discussion between the ratings did lead to some 
consensus among panelists. However, further attempts to drive consensus would have diluted 
true differences in opinion among panelists and, therefore, was not undertaken.” 
Comment: Specific areas of disagreement are noted in the discussion of results of ratings. 
16.  Link between evidence & recommendations. 
“The indications were constructed by echocardiography experts and modified on the 
basis of discussions among the Task Force and feedback from independent reviewers and the 
Technical Panel Whenever possible, indications were mapped to relevant clinical guidelines and 
key publications/references.” 
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Guideline 5: American Institute of Ultrasound in Medicine 
Practice Guideline for the Performance of the Musculoskeletal Ultrasound Examination (2007)  
(Analysis: Table 7) 
The first of two AIUM guidelines I reviewed is the Practice Guideline for the 
Performance of the Musculoskeletal Ultrasound Examination, published in 2007. 
This guideline addresses an ultrasound examination that may be performed in traditional 
settings by sonographers or physicians, but is commonly performed by physicians as a point-of-
care exam.  The thirteen-page guideline developed in collaboration with the American College of 
Radiology, includes eight sections.  The first, the “Introduction,” describes the collaborative 
nature of the guideline and identifies the target users. Standard organization recommendations 
are provided in Sections Two, Three, Four, Six, and Eight. Section Seven, “Equipment 
Specification,” describes optimal equipment for this exam.  
Section Five, “Specifications for Individual Examinations,” comprises the body of the 
guideline. In this section, authors recommend examination views and techniques for acquiring 
those views. Under appropriate subheadings, instructions are provided for examining each 
structure, and for using ultrasound to guide interventional procedures. At the conclusion of the 
guideline, the drafters and references are listed. Following in Table 7 I report attribute ratings for 
this guideline. (EASY TO READ, etc?? 
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Table 7: Practice Guideline for the Performance of the Musculoskeletal Ultrasound Examination 
(2007) 
 
Guideline Developer:  American Institute of Ultrasound in Medicine and the American 
College of Radiology  
 
Guideline Category(s)         GC1 ______     GC2  ______   GC3 ___x___     
 
Instructions: 
Rate Items 1 – 12 for ALL Guidelines. 
4 = Strongly Effective          
3 = Moderately Effective 
2 = Moderately Ineffective 
1 = Strongly Ineffective, or Missing 
GC1 and GC2 Guidelines:  Rate Items 13 – 16 * 
GC3 Guidelines : Rate Items 17 – 20 ** 
 
# ATTRIBUTE RATING COMMENTS 
 4 3 2 1  
1 Guideline objectives  x   The guideline states a general purpose, 
but no specific objectives. 
(see comments below) 
2 Health question(s)  x   Health questions are weakly implied 
throughout the guideline. 
(see comments below) 
3 Target population  x   The target population is indirectly 
identified according to indications. 
4 Target users  x   Physicians and sonographers are 
mentioned, but users are only identified 
by the nonspecific term “practitioner.” 
(see comments below) 
5 Updating procedure    x No plan for updating the document is 
provided. 
6 Recommendations  x   The guideline is highly informative, but 
most recommendations are weakly 
stated in nondirective language. 
(see comments below) 
7 Management options x    Optional positions are suggested to 
accommodate patient’s conditions; 
additional views are recommended 
when conditions warrant. 
(see comments below) 
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# ATTRIBUTE RATING COMMENTS 
8 Key recommendations   x  Recommendations are embedded 
within paragraphs, making them 
difficult to identify. 
(see comments below) 
9 Implementation tools    x The document does not incorporate any 
implementation tools. 
10 Monitoring, audit criteria, 
and suggestions for future 
research 
   x None are provided. 
11 Competing interests of 
CPG development group 
   x No conflict of interest statement is 
provided. 
12 Logical presentation x    Examination performance steps are 
logically ordered. 
 
*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY! 
13 Evidence selection criteria      
14 Evidence strengths, 
limitations 
     
15 Method for formulating 
recommendations 
     
16 Link between evidence & 
recommendations 
     
 
**Rate Items 17 – 20 for CG3 guidelines ONLY! 
17 Appropriateness criteria    x No criteria are provided. 
18 Clearly presented steps   x  Steps are difficult to pick out where 
they are embedded in paragraphs, and 
most are passively worded.  
19 Effective document design   x  The overall document is well-
organized, but it contains long, dense 
paragraphs, very little white space, and 
no graphics.   
20 Expert reference  x   The principal drafter was identified. 
This author is a leading expert in 
musculoskeletal ultrasound, and 
including his professional affiliation 







6 5  






1. Guideline objectives. 
“This guideline has been developed to assist practitioners performing a musculoskeletal 
ultrasound examination. While it is not possible to detect every abnormality, adherence to the 
following guidelines will maximize the probability of detecting most abnormalities that occur.” 
2. Health question(s). 
“The indications for ultrasound include, but are not limited to, evaluation of shoulder 
pain or dysfunction.” 
“These (previously mentioned) views should be used to determine if the tendon is 
properly positioned within the bicipital groove, subluxated, dislocated, or torn.” 
4. Target users. 
“This guideline has been developed to assist practitioners performing a musculoskeletal 
ultrasound examination.” 
“A physician must be available for consultation with the sonographer on a case-by-case 
basis. Ideally, the physician should be on-site and available to participate actively in the 
ultrasound examination when required.” 
18.       Clearly defined steps. 
“The palm is placed down on the table, or if the patient is supine, the forearm is placed 
across the abdomen, with the elbow flexed to 90o. The posterior joint space, triceps tendon, 
olecranon process, and olecranon bursa are assessed.” 
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Guideline 6: American Institute of Ultrasound in Medicine 
Practice Guideline for the Performance of Fetal Echocardiography (2010)  (Analysis: Table 8) 
The second AIUM guideline I reviewed is the Practice Guideline for the Performance of 
Fetal Echocardiography, published collaboratively with the American College of Obstetricians 
and Gynecologists and the Society for Maternal-Fetal Medicine, three years later in 2010. 
Although this is the first AIUM guideline dedicated to this topic, the exam has been performed 
by sonographers and physicians for several years and fits the criteria of “traditional.”   
Many sections of this guideline are similar in purpose to corresponding sections in the 
Musculoskeletal Guideline, but there are differences in usability features. In contrast to 
Musculoskeletal’s dense text discussion of recommended views, Fetal Echo lists views in 
bulleted lists. The Fetal Echo guideline also includes detailed illustrations, referenced in the text.  
There are also differences in transparency of links between evidence and recommendations. The 
Fetal Echo guideline contains embedded recommendations, a convention that has only been 
adopted for AIUM guidelines during the past two years. Also in the Fetal Echo guideline, the 
authors characterize the major imaging techniques as “Recommended” or “Optional,” depending 
on other patient conditions. The attribute ratings for this guideline follow in Table 8. 
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Table 8: Pactice Guideline for the Performance of Fetal Echocardiography (2010) 
 
Guideline Developer:  American Institute of Ultrasound in Medicine, American College 
of Radiology, American College of Obstetricians and Gynecologists, and the Society for 
Maternal-Fetal Medicine. Endorsed by the American College of Radiology. 
 
Guideline Category(s) :  GC1 ______     GC2  ______   GC3 __x____     
 
Instructions: 
Rate Items 1 – 12 for ALL Guidelines. 
4 = Strongly Effective          
3 = Moderately Effective 
2 = Moderately Ineffective 
1 = Strongly Ineffective, or Missing 
GC1 and GC2 Guidelines:  Rate Items 13 – 16 * 
GC3 Guidelines : Rate Items 17 – 20 ** 
 
# ATTRIBUTE RATING COMMENTS 
 4 3 2 1  
1 Guideline objectives  x   Objectives are obliquely stated; the 
expected outcome of applying the 
guideline is stated more directly. 
(see comments below) 
2 Health question(s) x    Conveyed through exam definition and 
indications 
(see comments below) 
3 Target population x    The target population is defined as 
fetuses between 18 and 22 weeks’ 
gestational age, or younger. 
4 Target users    x Target users are not identified. 
5 Updating procedure    x Not provided. 
6 Recommendations x    Recommended sonographic techniques 
are boldly identified and characterized 
according to strength. 
(see comments below) 
7 Management options x    An alternative scan option is suggested 
to manage a difficult scan; for some 
fetal conditions, additional exam 
components are suggested. 
(see comments below)  
8 Key recommendations x    Scan recommendations are identified 
clearly as noted in Item 6.. 
9 Implementation tools x    Guideline illustrations aid 
implementation. 
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# ATTRIBUTE RATING COMMENTS 
10 Monitoring, audit criteria, 
and future research 
   x None provided. 
11 Competing interests of 
CPG development group 
   x No conflict of interest statements are 
provided. 
12 Logical presentation x    The guideline is well organized and 
easy to follow. 
 
*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY! 
13 Evidence selection criteria      
14 Evidence strengths, 
limitations 
     
15 Method for formulating 
recommendations 
     
16 Link between evidence & 
recommendations 
     
 
**Rate Items 17 – 20 for CG3 guidelines ONLY! 
17 Appropriateness criteria  x   A criteria for judging appropriateness is 
provided indirectly. 
(see comments below) 
18 Clearly defined steps x    A “sequential segmental analysis” is 
provided and structures to include are 
listed. 
19 Effective document design x    The document is orderly, makes good 
use of white space, and it includes 
excellent graphics. 
20 Expert reference   x  No information is provided to convey 
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“Accurate prenatal diagnosis offers potential clinical benefit with regard to infant 
outcomes, especially in those cases that are likely to require prostaglandin infusion to maintain 
patency of the ductus arteriosus.” 
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“While it is not possible to detect every abnormality, adherence to the following 
guideline will maximize the probability of detecting most cases of clinically significant 
congenital heart disease.” 
2. Health questions 
“Fetal echocardiography is broadly defined as a detailed sonographic evaluation that is 
used to identify and characterize fetal heart anomalies before delivery.” 
6. Recommendations. (Note: The following are guideline headings) 
Gray Scale Imaging (Recommended)  
Doppler Sonography (Optional but Recommended for Suspected Cardiac Flow 
Abnormalities)  
M-Mode Echocardiography (Optional but Recommended for Cardiac Rate or Rhythm 
Abnormalities.) 
Cardiac Biometry (Optional but Can Be Considered in the Presence of Structural 
Anomalies) 
7. Management options 
“Technical limitations … can make a detailed heart evaluation very difficult because of 
acoustic shadowing, especially during the third trimester. It may be necessary to examine the 
patient at a different time if the heart is poorly visualized.” 
“Doppler Sonography (Optional but Recommended for Suspected Cardiac Flow 
Abnormalities)” 




17. Appropriateness criteria 
“A request for the examination must be originated by a physician or other appropriate 
health care provider familiar with the patient’s clinical situation and should be consistent with 
relevant legal and local health care facility requirements.” 
Summary of Findings 
Following is a review of the scores assigned to documents for each attribute. 
 
4) Guideline objectives:  
3/6 were rated “4.”  In the other three guidelines, objectives are stated obliquely or not at 
all. Effective strategies included: 
 a clear statement of topics and clinical imperative 
 a description of the diagnostic challenge, and the clinical and legal impacts of the clinical 
problem 
 a description of guideline objectives and expected outcomes 
5) “Health questions.”  
4/6 were rated “4.” Two received lower scores because questions were not provided or 
were only weakly implied. Characteristics of effectively presented questions included:  
 explicit wording,  
 bold font,  
 numbering,  
 prominent location  
 links with exam indications and recommended practices. 
. 
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6) “Target population.”.  
4/6 were rated “4.” In each of these guidelines, target populations are explicitly defined.  
In the other two guidelines, they are identified by indications but by no other characteristics. 
7) “Target users.”  
4/6 were rated “4.” These four guidelines identified the clinical groups considered 
qualified to perform the exam. In one of these guidelines, groups represented in the development 
process were identified; another provided suggestions for use of the guideline. In the two 
guidelines rated below “4,” target users are identified using nonspecific terms, or they are not 
identified at all. 
8) “Updating procedures.”  
Only these two guidelines stated a plan or timetable for updating. A third acknowledged 
the need for updating, but did not provide a plan or timetable.  
9) “Recommendations.”   
5/6 were rated “4.” The 6th guideline is highly informative, but conveys most 
recommendations in weak, nondirective language. Characteristics of effective presentation 
included:  
 unambiguous, directive language 
 strength grading  
 justification for each recommendation 
10) “Management Options.”  
6/6 were rated “4.” All six guidelines recommended optional approaches as warranted. 
11) “Key recommendations.”  
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4/6 were rated “4.” In the other two, the recommendations are not clearly identified as 
key answers to clinical questions, or the recommendations are embedded within paragraphs, 
making them difficult to identify. Characteristics of effective approaches included: 
 responsiveness to specific health questions 
 ease of identification under informative bolded heading 
 presentation in tables 
. 
12) “Implementation tools.”  
2/6 were rated “4.” The other guidelines fail to include or make reference to any 
implementation tools. Effective techniques included:  
 recommendations in well-formatted tables  
 illustrations  
13) “Monitoring, audit criteria, and future research.”  
2/6 were rated “4.” Those two guidelines suggested areas where future research is needed.  
14) “Competing interests of CPG development group.”  
2/6 were rated “4.” Disclosure strategies included:  
 a bolded conflict of interest statement 
 a strong, specific statement addressing potential relationships between CPG developers 
and industrial interests 
 listing of each author’s professional affiliation and role in the CPG development process. 
15) “Logical presentation.”  




Only three of the six guidelines were evaluated for the following attributes: 
16) “Evidence selection criteria”  
3/3 were rated “4.” In each, the details of the search and selection process are provided. 
17) “Evidence strengths, limitations”  
2/3 were rated “4.” In the third guideline, the evidence was qualitatively described as 
“relevant,” “objective,” and “nonbiased,” but no formal evidence-grading system is provided. 
Effective presentation strategies included:  
 description of the method used to interpret evidence and reduce bias 
 review of evidence both as a narrative to answer each question, and in evidentiary tables 
18) “Method for formulating recommendations”  
3/3 were rated “4.”  In each, the method was explicitly described. One of the three drew 
strongly on judgment and expert opinion for its recommendations. The committee’s formal use 
of a modified Delphi exercise is reported, and other steps the committee took to reduce the risk 
of bias are described. 
19) “Link between evidence and recommendations”  
3/3 were rated “4.” In two, each clinical question is explicitly answered with review of 
the relevant literature, and recommendations are provided as conclusions from the evidence.  In 
the 3rd guideline, the role of expert consensus as the link is explicitly stated. 
20) “Appropriateness criteria.”  




21) “Clearly presented steps.”  
1/3 guidelines were rated “4.” This guideline describes a “sequential segmental analysis” 
of structures. In the other two guidelines, the steps are clearly stated and concise, but they are 
passively worded and grouped in paragraphs, making the beginning of each step difficult to 
locate. 
22) “Effective document design”  
1/3 was rated “4.” This document displays an orderly format, makes good use of white 
space, and includes excellent graphics. In the other two documents, instructions are compressed 
into long, dense paragraphs, with very little white space and no graphics. 
23) “Expert Reference”  
1/3 was rated “4.” In this document, the expertise of the clinician guideline development 






CHAPTER FIVE: CONCLUSIONS 
In this concluding chapter I examine the guideline analyses described in Chapter Four 
and discuss the conclusions I reached regarding the key questions addressed by this thesis:    
 How should guidelines for emerging ultrasound applications be assessed? 
 Is it appropriate to develop guidelines for these applications? 
 If so, how can these guidelines best be constructed for validity and usability? 
How should guidelines for emerging ultrasound applications be assessed? 
Among the numerous instruments investigated as guideline quality assessment tools, the 
AGREE instrument has emerged as the most widely accepted. However, the developers of 
AGREE vaguely advise that for “some” guidelines, certain attributes designated by the 
instrument as quality components do not apply. As an example, AGREE authors identify 
“Management options” as a non-universal attribute. “… guidelines narrow in scope may not 
provide the full range of options for the management of the condition ” (??). In such cases, the 
authors suggest “having appraisers skip that item in the assessment process or [rate] the item as 
“1” (absence of information) and [provide] context about the score” (??). 
The purpose of my study was to address these vague exceptions in order to more 
appropriately evaluate guidelines for emerging applications. I theorized that the inconsistencies 
that limit applicability of AGREE across guidelines could relate to fundamental differences 
among guideline purposes – differences that could be defined and incorporated into AGREE as 
adjustment factors to make its rating scheme more universal.  
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To test my theory, I first considered characteristics that distinguish different types of 
guidelines. Beginning with the NGC Guideline Category definitions as a primary sorting tool, I 
grouped NGC Categories into three larger groups according to common characteristics, and 
considered how the AGREE tool could be adapted to assess different types of guidelines in a 
more tailored fashion. In particular, I considered the attributes related to evidence since these are 
problematic for emerging users’ guidelines: evidence selection criteria; evidence strengths and 
limitations; methods for formulating recommendations; and linking evidence with 
recommendations. 
I determined that guidelines that present options should, indeed, provide evidence of 
validity, and in the case of stratified options, use evidence to substantiate recommendations. 
Following that theory, guidelines in both CG1 and CG2 should be assessed according to these 
evidence criteria, and their scores on those attributes should correlate with quality. 
For ultrasound performance guidelines, particularly for emerging applications where the 
science is young and evidence scarce, however, guideline scores on these four AGREE attributes 
are likely to suggest poor quality. But I contend that “low” scores on these 4 items do not relate 
to the quality of ultrasound performance guidelines at all. I theorize that convoluting “evidence-
based” with “high quality” is misleading. Those 4 attributes are meaningful measures for 
“evidence-based” guidelines, but they are not natural or proper quality assessment considerations 
for performance guidelines. 
Following this theory that the four evidence evaluations are irrelevant to guidelines in the 
group I designated as CG3, I removed them from the assessment rubric for this group, replacing 
them with two, more relevant, validity attributes: expert reference, and appropriateness criteria. 
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I further tailored the instrument to assess usability of this particular group of documents. 
In contrast to guidelines that provide “if-then” recommendations, performance guidelines offer 
multi-step directions, so in addition to the two new validity attributes I added these two items to 
assess usability: clearly presented steps, and effective document design.  
To test my category-adjusted assessment approach, I evaluated six ultrasound guidelines. 
After assigning each guideline to a category, I rated each attribute and noted relevant text 
features. This detailed analysis revealed areas of document weakness that undermine the validity 
and usability of the guidelines, but it also illuminated writing approaches that strengthen them 
and add value. Regarding the category adjustments, I think they improve the rubric, reducing the 
instances of non-applicability. One exception is “Management Options.” I retained that attribute 
as universal, but for most of the guidelines in the group I analyzed, it was not truly relevant, and 
the scores I assigned and the examples I provided for most were arguably inflated. Another item 
that needs reconsideration is the attribute of “Logical presentation.”  The term is too vague and 
lent very little value to the assessments. 
My larger conclusion is that, while I believe tailoring assessment based on overall 
guideline purpose improves the tool’s sensitivity, its application needs to be refined. CPGs are 
complex documents, and most or all of the CPGs I reviewed contain sections that fit more than 
one of the guideline categories I identified.  Based on my experience with this study, I conclude 
that for a truly legitimate analysis, a guideline’s various sections should be analyzed individually. 
Global features, like describing an updating procedure or providing an overall guideline 
objective, should be addressed in all guidelines as simple, clear statements, but other attributes, 
particularly those that relate to evidence, are more qualitative and complex. In contrast to items 
like “updating procedure” which is a stand-alone statement, the qualitative attributes themselves 
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relate to statements. As an example, it seems likely that in the near future performance guidelines 
will need to build appropriateness justifications. While the performance portion of the guideline 
– its body - may not need a strict evidence base, perhaps appropriateness justifications will 
require it and should be judged according to the four evidence-related criteria.  
Is it appropriate to develop guidelines for these applications? 
One opinion is that guidelines should be written only for topics with a certain level of 
available evidence. Certainly unfounded recommendations should not be advanced, but this 
paper has included examples of strong recommendations made in the absence of high quality 
randomized controlled trials. Flu vaccination is one example of a treatment for which waiting to 
perform RCTs before writing guidelines would oppose patients’ best interests. In the case of 
ultrasound performance guidelines, the justification for proceeding without “evidence” is a little 
different, but I believe valid. I contend that as practices emerge and early adopters develop skill 
sets and knowledge worthy of being shared by others, the expertise of those individuals is 
sufficient support for a guideline. In all cases, however, the critical and incontrovertible caveat is 
that the guideline’s foundation needs to be fully and accurately conveyed by the guideline 
drafters.  
If so, how can these guidelines best be constructed for validity and usability? 
The Guidelines International Network of CPG developers, and others, recognize AGREE 
II not only as a reliable quality assessment tool, but also as a useful guideline development tool, 
Following that precedent, I developed a template for devising guidelines for emerging ultrasound 
applications. The template is based on my revision of the AGREE II instrument, with special 
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consideration for the validity and usability challenges inherent in developing guidelines for 













The quality of clinical practice guidelines depends on their validity and usability. 







Eight standard text components should appear in every CPG. For each of these 
components, guideline drafters should meet the following reporting standards: 
 
1)  Objectives: 
 Clearly state guideline objectives and rationale.  
 
2)  Health question(s): 
 Explicitly word and prominently display the health question(s) to be addressed. 
 
3)  Target population: 
 Describe the target population using humanizing language. 
 
4)  Target users: 
 Specify all potential user groups. 
 
5)  Schedule and procedure for updating: 
 Report the publisher’s revision schedule and procedure.   
 
6)  Implementation: 
 Provide implementation tools, or reference any related tools not described in the 
document. 
 
7)  Monitoring/audit criteria: 
 Supply monitoring and audit criteria, and identify areas for future research.  
 
8)  Conflicts of interest: 
 Disclose the presence or absence of competing interests for all members of the 




Specialized Validity Attributes 
Two validity attributes should appear in most or all CPGs, but their features will vary 
according to the purpose of the guideline.  
 
1)  Recommendations: 
 Describe the guideline collaboration process, disclosing areas of disagreement, 
the method used to resolve differences, and the areas where differences remained 
unresolved. 
For recommendations based on evidence from the literature: 
 Outline the evidence selection criteria. 
 Detail strengths and limitations of the evidence. 
 Provide unambiguous links between evidence and recommendations. 
For recommendations based on expert opinion or consensus: 
 Identify the principal drafter and other content experts. 
 List content experts’ credentials: professional affiliations, experience, and 
publication credits. 
 
2)  Appropriateness: 
 For evidence-based option stratification, appropriateness is intrinsically 
established. 
 For all others, provide evidence of cost-benefit outcomes for applying the 
<recommended procedure> to answer the <health question(s)> for the <target 
population> by the <target users>. 
 
Specialized Usability Attributes 
Guideline document usability features should suit the guideline’s purpose. 
 
When documenting evidence-supported recommendations: 
 Highlight and prominently display the health questions and recommendations. 
 Provide intuitively arranged explicit links between clinical questions, relevant 
evidence, and recommended practices. 
 
When describing procedures in a quick reference guide: 
 List concise, directive steps. 
 Begin each step on a new line. 
 Group steps under exam task headings. 
 Provide illustrations as needed. 
 
When describing procedures in an extended version: 
 Add technical tips and explanations of the purpose or goal of each step as 
indicated. 






Alfred Abuhamad, Beryl Benaceraf, Paula Woletz, and Bonnie Burke investigated the 
impact of an accreditation program on guidelines implementation, randomly selecting study 
subjects from among obstetric/gynecology practices accredited through the American Institute of 
Ultrasound in Medicine (AIUM)  (Abuhamad 2004). 
As part of the AIUM accreditation application, practices submit ultrasound case studies 
completed by their practitioners. Submitted obstetric and gynecologic studies are reviewed and 
scored for completeness according to criteria defined by AIUM Practice Guidelines for the 
Performance of Obstetric Ultrasound Examinations and for the Performance of the Ultrasound 
Examination of the Female Pelvis. To maintain accreditation, every three years practices must 
repeat the study submission process for reaccreditation.  
To evaluate whether participating in the AIUM accreditation program affects practice, for 
each practice included in this research, scores on reaccreditation case study submissions were 
compared to scores assigned on studies submitted at the time of initial accreditation.  
Results of this investigation confirmed that participants in the program improved scores 
in case studies submitted for reaccreditation. The authors propose that improved scores imply 
greater compliance with practice guidelines, “which should translate into enhancement of the 
quality of ultrasound practice.” These findings lend support to my premise that emerging users 
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The quality of clinical practice guidelines depends on their validity and usability. Following the 
principles described in this template will help guideline drafters promote those attributes. 
 
 




Guideline Category(s):    GC1  ___________   GC2   ____________   GC3___________ 
Instructions: 
Rate Items 1 – 12 for ALL Guidelines. 
1 = Strongly Effective          
2 = Moderately Effective 
3 = Moderately Ineffective 
4 = Strongly Ineffective, or Missing 
GC1 and GC2 Guidelines:  Rate Items 13 – 16 * 
GC3 Guidelines : Rate Items 17 – 20 ** 
# ATTRIBUTE RATING COMMENTS 
 1 2 3 4  
1 Guideline objectives      
2 Health question(s)      
3 Target population      
4 Target users      
5 Updating procedure      
6 Recommendations      
7 Management options      
8 Key recommendations      
9 Implementation tools      
10 Monitoring, audit criteria, and future research      
11 Competing interests of CPG development group      
12 Logical presentation      
 
*Rate Items 13 – 16 for CG1, CG2 guidelines ONLY! 
13 Evidence selection criteria      
14 Evidence strengths, limitations      
15 Method for formulating recommendations      
16 Link between evidence & recommendations      
 
**Rate Items 17 – 20 for CG3 guidelines ONLY! 
17 Appropriateness criteria      
18 Clearly defined steps      
19 Effective document design      
20 Expert reference      
 
TOTAL SCORES: 
     









Eight standard text components should appear in every CPG. Following these reporting 
standards will enhance guideline quality: 
 
1)  Objectives: 
 Clearly state guideline objectives and rationale.  
 
2)  Health question(s): 
 Explicitly word and prominently display the health question(s) to be addressed. 
 
3)  Target population: 
 Describe the target population using humanizing language. 
 
4)  Target users: 
 Specify all potential user groups. 
 
5)  Schedule and procedure for updating: 
 Report the publisher’s revision schedule and procedure.   
 
6)  Implementation: 
 Provide implementation tools, or reference any related tools not described in the 
document. 
 
7)  Monitoring/audit criteria: 
 Supply monitoring and audit criteria, and identify areas for future research.  
 
8)  Conflicts of interest: 
 Disclose the presence or absence of competing interests for all members of the 
CPG development group. 
 
 
Specialized Validity Attributes 
 
Two validity attributes should appear in most or all CPGs, but their features will vary 
according to the purpose of the guideline.  
 
1)  Recommendations: 
 Describe the guideline collaboration process, disclosing areas of disagreement, 
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the method used to resolve differences, and the areas where differences remained 
unresolved. 
 
For recommendations based on evidence from the literature: 
 Outline the evidence selection criteria. 
 Detail strengths and limitations of the evidence. 
 Provide unambiguous links between evidence and recommendations. 
 
For recommendations based on expert opinion or consensus: 
 Identify the principal drafter and other content experts. 
 List content experts’ credentials: professional affiliations, experience, and 
publication credits. 
 
2)  Appropriateness: 
 For evidence-based option stratification, appropriateness is intrinsically 
established. 
For all others, provide evidence of cost-benefit outcomes for applying the 
<recommended procedure> to answer the <health question(s)> for the <target 




Specialized Usability Attributes 
 
Guideline document usability features should suit the guideline’s purpose. 
 
When documenting evidence-supported recommendations: 
 Highlight and prominently display the health questions and recommendations. 
 Provide intuitively arranged explicit links between clinical questions, relevant 
evidence, and recommended practices. 
 
When describing procedures in a quick reference guide: 
 List concise, directive steps. 
 Begin each step on a new line. 
 Group steps under exam task headings. 
 Provide illustrations as needed. 
 
When describing procedures in an extended version: 
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